Disease - Clinical trilas for the 333 intractable diseases designated by the Ministry of Health, Labour and Welfare (MHLW), Japan💬 Info on mouse-over
ID | Disease name | Clinical trial Phase 1 / 2 / 3 / 4 |
Drug [ DrugBank ] |
Target gene Target pathway |
Domestic patients (1) MHLW, (2) Med expenses recipients (FY2020) |
Related info (in Japanese) |
1 | Spinal and bulbar muscular atrophy "Spinobulbar muscular atrophy", "SBMA", "Kennedy disease", "Kennedy-Alter-Sung syndrome" | 17 17 trials 0 / 9 / 2 / 1 💬 | 16 16 drugs [ 8 8 drugs ] | 10 10 genes 15 pathways | (1) 1,223 patients (2) 1,622 patients Age distribution💬 | Biobank Animal model |
2 | Amyotrophic lateral sclerosis "ALS" | 508 508 trials 252 / 235 / 151 / 35 💬 | 530 530 drugs [ 146 146 drugs ] | 170 170 genes 221 pathways | (1) 9,096 patients (2) 10,514 patients Age distribution💬 | Biobank Animal model |
3 | Spinal muscular atrophy "Myelopathic muscular atrophy", "SMA I", "Werdnig-Hoffman disease", "SMA II", "Dubowitz disease", "SMA III", "Kugelberg-Welander disease", "SMA IV" | 179 179 trials 141 / 107 / 75 / 28 💬 | 102 102 drugs [ 26 26 drugs ] | 52 52 genes 78 pathways | (1) 712 patients (2) 921 patients Age distribution💬 | Biobank Pediatric diseases |
4 | Primary lateral sclerosis "PLS" | 6 6 trials 3 / 2 / 0 / 1 💬 | 16 16 drugs [ 8 8 drugs ] | 19 19 genes 32 pathways | (1) 175 patients (By the research group) (2) 127 patients Age distribution💬 | Biobank |
5 | Progressive supranuclear palsy "PSP" | 82 82 trials 48 / 35 / 12 / 6 💬 | 107 107 drugs [ 36 36 drugs ] | 60 60 genes 90 pathways | (1) About 8,100 patients (2) 12,766 patients Age distribution💬 | Biobank |
6 | Parkinson disease | 2,123 2,123 trials 864 / 632 / 514 / 272 💬 | 2,046 2,046 drugs [ 324 324 drugs ] | 183 183 genes 198 pathways | (1) About 108,800 patients (estimated from Parkinson disease related diseases) (2) 142,375 patients Age distribution💬 | Biobank |
7 | Corticobasal degeneration "Corticobasal syndrome", "CBD" | 16 16 trials 5 / 2 / 1 / 0 💬 | 33 33 drugs [ 11 11 drugs ] | 6 6 genes 13 pathways | (1) 3,500 patients (2) 4,749 patients Age distribution💬 | |
8 | Huntington disease "Huntington chorea" | 197 197 trials 127 / 103 / 42 / 20 💬 | 171 171 drugs [ 54 54 drugs ] | 82 82 genes 144 pathways | (1) 933 patients (2) 950 patients Age distribution💬 | Biobank Animal model |
9 | Neuroacanthocytosis "Choreoacanthocytosis", "Chorea-acanthocytosis", "Levine-Critchley syndrome", "McLeod syndrome", "Huntington disease-like 2", "HDL2", "Pantothenate kinase-associated neurodegeneration", "PKAN", "Hallervorden-Spatz syndrome" | 0 - | 0 - | 0 - | (1) Less than 100 patients (By the research group) (2) 33 patients Age distribution💬 | Pediatric diseases |
10 | Charcot-Marie-Tooth disease "CMT" | 31 31 trials 23 / 16 / 16 / 4 💬 | 38 38 drugs [ 9 9 drugs ] | 11 11 genes 14 pathways | (1) 6,250 patients (By the research group) (2) 774 patients Age distribution💬 | Biobank Animal model Pediatric diseases |
11 | Myasthenia "MG" | 226 226 trials 159 / 88 / 117 / 37 💬 | 172 172 drugs [ 45 45 drugs ] | 43 43 genes 118 pathways | (1) 22,998 patients (2) 25,416 patients Age distribution💬 | Pediatric diseases |
12 | Congenital myasthenic syndrome "End-plate acetylcholine receptor deficiency", "Sodium channel myasthenia", "End-plate acetylcholine esterase deficiency", "Dok-7 myasthenia" | 5 5 trials 1 / 0 / 0 / 0 💬 | 7 7 drugs [ 3 3 drugs ] | 5 5 genes 12 pathways | (1) Less than 100 patients (By the research group) (2) 12 patients Age distribution💬 | |
13 | Multiple sclerosis/Neuromyelitis optica "Multiple sclerosis", "Neuromyelitis optica", "MS", "NMOSD", "Devic disease", "Balo concentric sclerosis", "Baló concentric sclerosis" | 3,050 3,050 trials 1316 / 758 / 1042 / 507 💬 | 2,147 2,147 drugs [ 348 348 drugs ] | 244 244 genes 228 pathways | (1) 17,073 patients (2) 21,437 patients Age distribution💬 | Biobank Pediatric diseases |
14 | Chronic inflammatory demyelinating polyneuropathy "Chronic inflammatory demyelinating poly (radiculo) neuropathy", "Multifocal motor neuropathy", "CIDP" | 145 145 trials 60 / 69 / 71 / 18 💬 | 139 139 drugs [ 23 23 drugs ] | 12 12 genes 21 pathways | (1) 4,633 patients (2) 5,158 patients Age distribution💬 | Pediatric diseases |
15 | Inclusion body myositis | 39 39 trials 30 / 18 / 23 / 5 💬 | 32 32 drugs [ 11 11 drugs ] | 11 11 genes 119 pathways | (1) 1,000 patients (By the research group) (2) 690 patients Age distribution💬 | Biobank |
16 | Crow-Fukase syndrome "POEMS syndrome", "Polyneuropathy, organomegaly, endocrinopathy, m-protein, and skin changes syndrome", "Takatsuki disease", "PEP syndrome", "Polyneuropathy, endocrinopathy, plasma cell dyscrasia syndrome" | 12 12 trials 0 / 9 / 2 / 0 💬 | 18 18 drugs [ 8 8 drugs ] | 5 5 genes 79 pathways | (1) 340 patients (By the research group) (2) 215 patients Age distribution💬 | |
17 | Multiple system atrophy "MSA-C", "MSA-P", "Olivopontocerebellar atrophy", "OPCA", "Striatonigral degeneration", "Shy-Drager syndrome" | 107 107 trials 79 / 34 / 40 / 13 💬 | 153 153 drugs [ 48 48 drugs ] | 59 59 genes 104 pathways | (1) 11,733 patients (2) 11,694 patients Age distribution💬 | Biobank |
18 | Spinocerebellar degeneration "SCD", "Spinocerebellar ataxia type I", "SCA1", "Spinocerebellar ataxia type II", "SCA2", "Spinocerebellar ataxia type III", "SCA3", "Machado-Joseph disease", "Spinocerebellar ataxia type VI", "SCA6", "Spinocerebellar ataxia type VII", "SCA7", "Spinocerebellar ataxia type X", "SCA10", "Spinocerebellar ataxia type XII", "SCA12", "Dentatorubural pallidoluysian atrophy", "Dentatorubropallidoluysial atrophy", "DRPLA", "Naito-Koyanagi disease", "Friedreich ataxia", "FRDA", "Ataxia with vitamin E deficiency", "AVED", "Early-onset ataxia with ocular motor ataxia and hypoalbuminemia", "EOAH" | 59 59 trials 15 / 32 / 14 / 4 💬 | 78 78 drugs [ 28 28 drugs ] | 44 44 genes 59 pathways | (1) 25,447 patients (2) 27,365 patients Age distribution💬 | Pediatric diseases |
19 | Lysosomal storage disease "Lysosomal disease", "Gaucher disease", "Niemann-Pick disease", "Niemann-Pick type C", "GM1-gangliosidosis", "GM1-gangliosidoses", "GM2-gangliosidosis", "GM2-gangliosidoses", "Tay-Sachs disease", "Sandhoff disease", "Krabbe disease", "Metachromatic leukodystrophy", "Multiple-sulfatase deficiency", "Farber disease", "Mucopolysaccharidosis type I", "Mucopolysaccharidosis I", "MPS I", "Hurler syndrome", "Scheie syndrome", "Mucopolysaccharidosis type II", "Mucopolysaccharidosis II", "MPS II", "Hunter syndrome", "Mucopolysaccharidosis type III", "Mucopolysaccharidosis III", "MPS III", "Sanfilippo syndrome", "Mucopolysaccharidosis type IV", "Mucopolysaccharidosis IV", "MPS IV", "MPS IVA", "Morquio syndrome", "Morquio A syndrome", "Mucopolysaccharidosis type VI", "Mucopolysaccharidosis VI", "MPS VI", "Maroteaux-Lamy syndrome", "Mucopolysaccharidosis type VII", "Mucopolysaccharidosis VII", "MPS VII", "Sly syndrome", "Mucopolysaccharidosis type IX", "Mucopolysaccharidosis IX", "MPS IX", "Hyaluronidase deficiency", "Sialidosis", "Galactosialidosis", "Mucolipidosis II", "Mucolipidosis type II", "I-cell disease", "Mucolipidosis III", "Mucolipidosis type III", "Alpha-Mannosidosis", "Alpha-Mannosidase Deficiency", "Beta-Mannosidosis", "Beta-Mannosidase Deficiency", "Fucosidosis", "Aspartylglucosaminuria", "Schindler disease", "Kanzaki disease", "Pompe disease", "Acid lipase deficiency", "Wolman disease", "Cholesterol ester storage disease", "Danon disease", "Free sialic acid storage disease", "Salla disease", "Ceroid lipofuscinosis", "Fabry disease", "Cystinosis" | 784 784 trials 555 / 331 / 272 / 125 💬 | 673 673 drugs [ 101 101 drugs ] | 68 68 genes 184 pathways | (1) 911 patients (2) 1,529 patients Age distribution💬 | Animal model Pediatric diseases |
20 | Adrenoleukodystrophy "Adrenomyeloneuropathy", "AMN" | 49 49 trials 44 / 30 / 26 / 7 💬 | 86 86 drugs [ 29 29 drugs ] | 18 18 genes 112 pathways | (1) 193 patients (2) 255 patients Age distribution💬 | Pediatric diseases |
21 | Mitochondrial disease | 23 23 trials 6 / 12 / 4 / 1 💬 | 29 29 drugs [ 28 28 drugs ] | 44 44 genes 65 pathways | (1) 1,087 patients (2) 1,602 patients Age distribution💬 | Biobank Animal model Pediatric diseases |
22 | Moyamoya disease "Occlusive disease in circle of Willis" | 11 11 trials 1 / 1 / 1 / 2 💬 | 18 18 drugs [ 11 11 drugs ] | 28 28 genes 43 pathways | (1) 15,177 patients (2) 13,894 patients Age distribution💬 | Biobank Pediatric diseases |
23 | Prion disease "Creutzfeldt-Jakob disease", "CJD", "Gerstmann-Straussler-Scheinker syndrome", "Fatal familial insomnia", "Kuru disease" | 4 4 trials 0 / 1 / 0 / 0 💬 | 5 5 drugs [ 2 2 drugs ] | 0 - | (1) 584 patients (2) 481 patients Age distribution💬 | |
24 | Subacute sclerosing panencephalitis "SSPE" | 0 - | 0 - | 0 - | (1) About 100 patients (2) 72 patients Age distribution💬 | Biobank Pediatric diseases |
25 | Progressive multifocal leukoencephalopathy "PML", "Leukoencephalopathy, progressive multifocal" | 23 23 trials 2 / 5 / 0 / 2 💬 | 33 33 drugs [ 20 20 drugs ] | 7 7 genes 36 pathways | (1) Less than 100 patients (By the research group) (2) 59 patients Age distribution💬 | |
26 | HTLV-1-associated myelopathy "Tropical spastic paraparesis", "HTLV-1", "HTLV-I-associated myelopathy" | 26 26 trials 8 / 13 / 10 / 0 💬 | 46 46 drugs [ 27 27 drugs ] | 37 37 genes 123 pathways | (1) 3,000 patients (By the research group) (2) 1,027 patients Age distribution💬 | Biobank |
27 | Idiopathic basal ganglia calcification "IBGC", "Fahr disease", "FIBGC", "Primary familial brain calcification", "PFBC" | 0 - | 0 - | 0 - | (1) 200 patients (By the research group) (2) 115 patients Age distribution💬 | |
28 | Systemic amyloidosis "AL amyloidosis", "Immunoglobulin light chain amyloidosis", "Amyloid light-chain amyloidosis", "Familial amyloidosis", "Familial amyloid polyneuropathy", "Senile transthyretin amyloidosis", "Senile TTR amyloidosis" | 212 212 trials 102 / 97 / 78 / 16 💬 | 234 234 drugs [ 72 72 drugs ] | 54 54 genes 170 pathways | (1) 1,802 patients (2) 3,892 patients Age distribution💬 | Pediatric diseases |
29 | Ullrich disease "Ullrich congenital muscular dystrophy", "Collagen VI-related myopathy" | 0 - | 0 - | 0 - | (1) About 300 patients (By the research group) (2) 22 patients Age distribution💬 | Pediatric diseases |
30 | Distal myopathy "Distal muscular dystrophy", "Miyoshi myopathy", "Distal dysferlinopathy", "DMRV/GNE myopathy", "Oculopharyngodistal myopathy" | 13 13 trials 1 / 5 / 10 / 0 💬 | 16 16 drugs [ 3 3 drugs ] | 1 1 gene 1 pathway | (1) 400 patients (By the research group) (2) 295 patients Age distribution💬 | Animal model |
31 | Bethlem myopathy "Beth Rem myopathy" | 0 - | 0 - | 0 - | (1) Less than 100 patients (By the research group) (2) 16 patients Age distribution💬 | Pediatric diseases |
32 | Autophagic vacuolar myopathy "Danon disease", "X-linked myopathy with excessive autophagy", "XMEA" | 1 1 trial 1 / 0 / 0 / 0 💬 | 1 1 drug [ 0 - ] | 0 - | (1) Less than 100 patients (By the research group) (2) 8 patients Age distribution💬 | Pediatric diseases |
33 | Schwartz-Jampel syndrome "Schwarz-Yanperu syndrome", "SJS", "Myotonic chondrodystrophy", "Cartilage dystrophic myotonia", "Stuve-Wiedemann syndrome", "Stüve-Wiedemann syndrome" | 0 - | 0 - | 0 - | (1) Less than 100 patients (By the research group) (2) 1 patient Age distribution💬 | Pediatric diseases |
34 | Neurofibromatosis "NF1", "von Recklinghausen disease", "NF2" | 120 120 trials 47 / 79 / 9 / 8 💬 | 182 182 drugs [ 72 72 drugs ] | 84 84 genes 194 pathways | (1) 3,588 patients (2) 4,218 patients Age distribution💬 | Biobank Pediatric diseases |
35 | Pemphigus | 87 87 trials 59 / 36 / 41 / 10 💬 | 114 114 drugs [ 37 37 drugs ] | 17 17 genes 158 pathways | (1) About 6,000 patients (2) 3,515 patients Age distribution💬 | Biobank |
36 | Epidermolysis bullosa "EBS", "JEB", "DDEB", "RDEB", "Kindler syndrome" | 147 147 trials 110 / 86 / 50 / 16 💬 | 170 170 drugs [ 40 40 drugs ] | 32 32 genes 113 pathways | (1) 347 patients (2) 309 patients Age distribution💬 | Biobank Pediatric diseases |
37 | Generalised pustular psoriasis "Pustular psoriasis", "Herpetic impetigo", "Generalization of acrodermatitis continua", "Generalization of dermatitis continua of the extremities" | 58 58 trials 41 / 24 / 32 / 11 💬 | 50 50 drugs [ 18 18 drugs ] | 17 17 genes 96 pathways | (1) 2,072 patients (2) 2,058 patients Age distribution💬 | Pediatric diseases |
38 | Stevens-Johnson syndrome "SJS", "Mucocutaneous ocular syndrome" | 11 11 trials 10 / 7 / 3 / 2 💬 | 19 19 drugs [ 8 8 drugs ] | 14 14 genes 98 pathways | (1) About 1,500 patients (2) 219 patients Age distribution💬 | Pediatric diseases |
39 | Toxic epidermal necrolysis "Toxic epidermal necrosis", "TEN" | 11 11 trials 4 / 6 / 2 / 1 💬 | 18 18 drugs [ 8 8 drugs ] | 11 11 genes 101 pathways | (1) About 200 patients (2) 68 patients Age distribution💬 | Pediatric diseases |
40 | Takayasu arteritis "Aortitis syndrome", "Pulseless disease" | 22 22 trials 1 / 4 / 6 / 2 💬 | 46 46 drugs [ 20 20 drugs ] | 22 22 genes 111 pathways | (1) About 7,000 patients (2) 4,730 patients Age distribution💬 | Biobank Pediatric diseases |
41 | Giant cell arteritis "Temporal arteritis" | 108 108 trials 94 / 42 / 64 / 21 💬 | 111 111 drugs [ 32 32 drugs ] | 33 33 genes 121 pathways | (1) About 700 patients (By the research group) (2) 1,716 patients Age distribution💬 | |
42 | Polyarteritis nodosa "PAN" | 14 14 trials 0 / 5 / 6 / 2 💬 | 27 27 drugs [ 16 16 drugs ] | 26 26 genes 102 pathways | (1) [Disease ID 42-43 total] 9,610 patients (2) 2,347 patients Age distribution💬 | Pediatric diseases |
43 | Microscopic polyangiitis "MPA" | 85 85 trials 76 / 39 / 42 / 24 💬 | 80 80 drugs [ 19 19 drugs ] | 13 13 genes 85 pathways | (1) [Disease ID 42-43 total] 9,610 patients (2) 10,681 patients Age distribution💬 | Pediatric diseases |
44 | Wegener granulomatosis "Multiple vasculitis granulomatous disease", "Granulomatosis with polyangiitis" | 84 84 trials 86 / 35 / 48 / 25 💬 | 88 88 drugs [ 22 22 drugs ] | 13 13 genes 37 pathways | (1) 1,942 patients (2) 3,196 patients Age distribution💬 | Pediatric diseases |
45 | Eosinophilic granulomatosis with Polyangiitis "EGPA", "Eosinophilic multiple vasculitis granulomatous disease", "Allergic granulomatous angiitis", "Churg-Strauss syndrome" | 27 27 trials 8 / 7 / 12 / 5 💬 | 41 41 drugs [ 18 18 drugs ] | 18 18 genes 98 pathways | (1) About 1,800 patients (By the research group) (2) 5,162 patients Age distribution💬 | Pediatric diseases |
46 | Malignant rheumatoid arthritis "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis" | 4,183 4,183 trials 1485 / 924 / 1128 / 635 💬 | 2,538 2,538 drugs [ 401 401 drugs ] | 183 183 genes 219 pathways | (1) 6,255 patients (2) 5,281 patients Age distribution💬 | |
47 | Buerger disease "Thromboangiitis obliterans" | 7 7 trials 0 / 3 / 0 / 0 💬 | 9 9 drugs [ 4 4 drugs ] | 4 4 genes 13 pathways | (1) 7,109 patients (2) 2,259 patients Age distribution💬 | Biobank |
48 | Primary antiphospholipid syndrome "Primary antiphospholipid antibody syndrome", "Primary APS", "PAPS" | 3 3 trials 0 / 0 / 1 / 0 💬 | 4 4 drugs [ 3 3 drugs ] | 0 - | (1) About 10,000 patients (By the research group) (2) 797 patients Age distribution💬 | Pediatric diseases |
49 | Systemic lupus erythematosus "SLE" | 827 827 trials 503 / 335 / 223 / 123 💬 | 638 638 drugs [ 168 168 drugs ] | 108 108 genes 191 pathways | (1) 60,122 patients (2) 64,468 patients Age distribution💬 | Animal model Pediatric diseases |
50 | Dermatomyositis "Polymyositis" | 157 157 trials 85 / 65 / 48 / 21 💬 | 207 207 drugs [ 76 76 drugs ] | 47 47 genes 142 pathways | (1) About 19,500 patients (2) 24,894 patients Age distribution💬 | Biobank Pediatric diseases |
51 | Scleroderma "Systemic sclerosis", "SSc", "dcSSc", "lcSSc" | 466 466 trials 296 / 217 / 142 / 68 💬 | 536 536 drugs [ 142 142 drugs ] | 110 110 genes 210 pathways | (1) About 20,000 patients estimated though the latest number of patients unknown (2) 27,647 patients Age distribution💬 | Biobank Pediatric diseases |
52 | Mixed connective tissue disease | 4 4 trials 0 / 1 / 1 / 0 💬 | 6 6 drugs [ 3 3 drugs ] | 1 1 gene 1 pathway | (1) 11,005 patients (2) 10,182 patients Age distribution💬 | Pediatric diseases |
53 | Sjogren syndrome "Sjögren syndrome" | 234 234 trials 103 / 141 / 35 / 31 💬 | 270 270 drugs [ 85 85 drugs ] | 49 49 genes 174 pathways | (1) About 66,300 patients (By the research group) (2) 17,628 patients Age distribution💬 | Biobank Pediatric diseases |
54 | Adult still disease "Adult-onset Stills disease" | 2 2 trials 0 / 0 / 0 / 0 💬 | 1 1 drug [ 1 1 drug ] | 1 1 gene 12 pathways | (1) About 4,800 patients (By the research group) (2) 4,148 patients Age distribution💬 | |
55 | Relapsing polychondritis | 7 7 trials 1 / 3 / 0 / 0 💬 | 10 10 drugs [ 9 9 drugs ] | 12 12 genes 98 pathways | (1) About 500 patients (By the research group) (2) 840 patients Age distribution💬 | Pediatric diseases |
56 | Behcet disease "Behçet disease" | 68 68 trials 10 / 20 / 18 / 5 💬 | 87 87 drugs [ 31 31 drugs ] | 36 36 genes 113 pathways | (1) 20,035 patients (2) 15,537 patients Age distribution💬 | Pediatric diseases |
57 | Idiopathic dilated cardiomyopathy | 12 12 trials 3 / 6 / 1 / 3 💬 | 25 25 drugs [ 12 12 drugs ] | 9 9 genes 33 pathways | (1) 27,968 patients (2) 20,387 patients Age distribution💬 | Biobank Animal model Pediatric diseases |
58 | Hypertrophic cardiomyopathy | 92 92 trials 35 / 42 / 31 / 14 💬 | 126 126 drugs [ 35 35 drugs ] | 40 40 genes 141 pathways | (1) 4,667 patients (2) 4,481 patients Age distribution💬 | Biobank Pediatric diseases |
59 | Restricted cardiomyopathy "Restrictive cardiomyopathy", "Constrictive cardiomyopathy" | 0 - | 0 - | 0 - | (1) 50 patients (2) 64 patients Age distribution💬 | Pediatric diseases |
60 | Aplastic anemia | 218 218 trials 62 / 136 / 27 / 16 💬 | 362 362 drugs [ 81 81 drugs ] | 39 39 genes 155 pathways | (1) 10,287 patients (2) 8,724 patients Age distribution💬 | Pediatric diseases |
61 | Autoimmune hemolytic anemia "AIHA", "WAIHA", "Cold agglutinin disease", "CAD", "Paroxysmal cold hemoglobinuria", "MAIHA", "Evans syndrome" | 90 90 trials 31 / 42 / 43 / 6 💬 | 72 72 drugs [ 23 23 drugs ] | 19 19 genes 147 pathways | (1) About 2,600 patients (2) 1,275 patients Age distribution💬 | Pediatric diseases |
62 | Paroxysmal nocturnal hemoglobinuria "PNH" | 202 202 trials 154 / 85 / 117 / 33 💬 | 120 120 drugs [ 25 25 drugs ] | 15 15 genes 90 pathways | (1) About 400 patients (2) 927 patients Age distribution💬 | Pediatric diseases |
63 | Idiopathic thrombocytopenic purpura "Primary immune thrombocytopenia" | 311 311 trials 164 / 70 / 130 / 54 💬 | 185 185 drugs [ 39 39 drugs ] | 43 43 genes 132 pathways | (1) 24,956 patients (2) 18,793 patients Age distribution💬 | Pediatric diseases |
64 | Thrombotic thrombocytopenic purpura "TTP", "Upshaw-Schulman syndrome", "USS" | 74 74 trials 29 / 26 / 39 / 7 💬 | 76 76 drugs [ 19 19 drugs ] | 15 15 genes 57 pathways | (1) Estimated occurrence: About 500 patients per year (2) 361 patients Age distribution💬 | Animal model Pediatric diseases |
65 | Primary immunodeficiency "X-SCID", "Reticular dysgenesis", "Adenosine deaminase deficiency", "Omenn syndrome", "Purine nucleoside phosphorylase deficiency", "CD8 deficiency", "ZAP-70 deficiency", "MHC class I deficiency", "MHC class II deficiency", "Combined immunodeficiency", "Wiskott-Aldrich syndrome", "Telangiectasia ataxia", "Nijmegen breakage syndrome", "Bloom syndrome", "Immunodeficiency, centromere region instability, facial anomalies syndrome", "ICF syndrome", "PMS2 deficiency", "Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome", "RIDDLE syndrome", "Schimke syndrome", "Netherton syndrome", "Thymic hypoplasia", "DiGeorge syndrome", "22q11.2 deletion syndrome", "Hyper-IgE syndrome", "Hepatic venoocclusive immunodeficiency", "Immunodeficiency with central hepatic vein atresia", "Dyskeratosis congenita", "X-linked agammaglobulinaemia", "Common variable immunodeficiency", "Hyper-IgM syndrome", "Isolated IgG subclass deficiency", "Selective IgA deficiency", "Specific antibody production deficiency", "Infant transient hypogammaglobulinemia", "Chédiak-Higashi syndrome", "Chediak-Higashi syndrome", "X-linked lymphoproliferative syndrome", "SAP deficiency", "SH2D1A/SLAM-associated protein deficiency", "XIAP deficiency", "X-linked inhibitor of apoptosis deficiency", "Autoimmune lymphoproliferative syndrome", "ALPS", "Familial hemophagocytic syndrome", "Perforin deficiency", "Munc13-4 deficiency", "Syntaxin 11 deficiency", "Munc18-2 deficiency", "Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy", "APECED", "Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome", "IPEX syndrome", "CD25 deficiency", "ITCH deficiency", "Primary phagocytic dysfunction", "Severe congenital neutropenia", "Cyclic neutropenia", "Hermanskyi-Pudlak syndrome type 2", "Hermanskyi-Pudlak syndrome 2", "Griscelli syndrome type 2", "Griscelli syndrome 2", "p14 deficiency", "Warts, hypogammaglobulinemia, infections, myelokathexis syndrome", "WHIM syndrome", "Glycogen storage disease type Ib", "Leukocyte adhesion deficiency", "Shwachman-Diamond syndrome", "Chronic granulomatous disease", "Myeloperoxidase deficiency", "Mendelian susceptibility to mycobacterial disease", "MSMD", "Anhidrotic ectodermal dysplasia with immunodeficiency", "EDA-ID", "Interleukin-1 receptor-associated kinase-4 deficiency", "IRAK4 deficiency", "IMyD88 deficiency", "Chronic mucocutaneous candidiasis", "Epidermodysplasia verruciformis", "Herpes simplex encephalitis", "Caspase recruitment domain family member 9 deficiency", "CARD9 deficiency", "Trypanosomiasis", "Congenital complement deficiency", "C1q deficiency", "CC1r deficiency", "CC1s deficiency", "CC2 deficiency", "CC3 deficiency", "CC4 deficiency", "CC5 deficiency", "CC6 deficiency", "CC7 deficiency", "CC8 deficiency", "CC9 deficiency", "Factor D deficiency", "Properdin deficiency", "Factor I deficiency", "Factor H deficiency", "MASP1 deficiency", "3MC syndrome", "Mannose-binding protein-associated serine protease 2 deficiency", "MASP2 deficiency", "FCN3", "Hereditary angioedema type 1", "Hereditary angioedema type I", "C1 inhibitor deficiency type 1", "C1 inhibitor deficiency type I", "Hereditary angioedema type 2", "Hereditary angioedema type II", "C1 inhibitor deficiency type 2", "C1 inhibitor deficiency type II", "Hereditary angioedema type 3", "Hereditary angioedema type III", "C1 inhibitor deficiency type 3", "C1 inhibitor deficiency type III" | 413 413 trials 209 / 170 / 134 / 54 💬 | 581 581 drugs [ 97 97 drugs ] | 68 68 genes 202 pathways | (1) 1,383 patients (2) 1,943 patients Age distribution💬 | Animal model Pediatric diseases |
66 | IgA nephropathy "IgA nephritis", "Berger disease", "IgA-IgG nephropathy" | 199 199 trials 49 / 60 / 68 / 34 💬 | 214 214 drugs [ 57 57 drugs ] | 32 32 genes 128 pathways | (1) About 33,000 patients (By the research group) (2) 12,699 patients Age distribution💬 | Biobank Animal model Pediatric diseases |
67 | Polycystic kidney disease "PKD", "PCKD", "Polycystic kidney", "ADPKD", "ARPKD" | 186 186 trials 113 / 73 / 86 / 30 💬 | 196 196 drugs [ 47 47 drugs ] | 35 35 genes 146 pathways | (1) About 31,000 patients (By the research group) (2) 11,935 patients Age distribution💬 | Animal model Pediatric diseases |
68 | Ossification of the ligamentum flavum "Ossification of ligamentum flavum", "OLF" | 2 2 trials 0 / 0 / 0 / 0 💬 | 4 4 drugs [ 4 4 drugs ] | 1 1 gene 3 pathways | (1) 2,360 patients (2) 6,715 patients Age distribution💬 | |
69 | Ossification of posterior longitudinal ligament | 1 1 trial 0 / 0 / 0 / 0 💬 | 1 1 drug [ 1 1 drug ] | 0 - | (1) 33,346 patients (2) 36,401 patients Age distribution💬 | |
70 | Spinal stenosis "Extensive spinal canal stenosis" | 91 91 trials 12 / 13 / 8 / 25 💬 | 195 195 drugs [ 54 54 drugs ] | 60 60 genes 85 pathways | (1) 5,944 patients (2) 5,845 patients Age distribution💬 | |
71 | Idiopathic osteonecrosis of the femoral head "Idiopathic femoral head necrosis" | 3 3 trials 0 / 1 / 0 / 0 💬 | 5 5 drugs [ 4 4 drugs ] | 4 4 genes 10 pathways | (1) 15,388 patients (2) 20,003 patients Age distribution💬 | |
72 | Pituitary ADH secretion disorder "Inappropriate antidiuretic hormone secretion", "Syndrome of inappropriate secretion of antidiuretic hormone", "Inappropriate ADH syndrome", "Syndrome of inappropriate ADH", "Central diabetes insipidus", "Syndrome of inappropriate secretion of ADH", "SIADH" | 36 36 trials 2 / 5 / 12 / 1 💬 | 22 22 drugs [ 5 5 drugs ] | 2 2 genes 4 pathways | (1) [Disease ID 72-78 total] 17,069 patients (2) 3,641 patients Age distribution💬 | Pediatric diseases |
73 | TSH-secreting pituitary adenoma "Pituitary TSH secretion hyperthyroidism" | 1 1 trial 0 / 0 / 1 / 0 💬 | 3 3 drugs [ 2 2 drugs ] | 0 - | (1) [Disease ID 72-78 total] 17,069 patients (2) 175 patients Age distribution💬 | Pediatric diseases |
74 | Prolactin secreting pituitary adenoma "Pituitary PRL secretion hyperthyroidism", "Prolactinoma", "Prolactin secreting adenoma" | 18 18 trials 3 / 6 / 1 / 1 💬 | 33 33 drugs [ 10 10 drugs ] | 16 16 genes 63 pathways | (1) [Disease ID 72-78 total] 17,069 patients (2) 2,260 patients Age distribution💬 | Pediatric diseases |
75 | Cushing disease "Cushing" | 191 191 trials 165 / 81 / 84 / 47 💬 | 172 172 drugs [ 48 48 drugs ] | 61 61 genes 121 pathways | (1) [Disease ID 72-78 total] 17,069 patients (2) 926 patients Age distribution💬 | Pediatric diseases |
76 | Pituitary gonadotropin secretion hyperthyroidism "Gonadotropin secreting pituitary adenoma", "Central precocious puberty", "Gonadotropin producing pituitary adenoma" | 25 25 trials 0 / 0 / 8 / 8 💬 | 41 41 drugs [ 11 11 drugs ] | 3 3 genes 10 pathways | (1) [Disease ID 72-78 total] 17,069 patients (2) 39 patients Age distribution💬 | Pediatric diseases |
77 | Growth hormone secreting pituitary adenoma "Pituitary growth hormone secretion hyperthyroidism" | 1 1 trial 0 / 0 / 0 / 0 💬 | 1 1 drug [ 1 1 drug ] | 2 2 genes 19 pathways | (1) [Disease ID 72-78 total] 17,069 patients (2) 4,613 patients Age distribution💬 | Pediatric diseases |
78 | Hypopituitarism "Anterior pituitary hypothyroidism", "Syndrome of abnormal secretion of gonadotropin", "Hyposecretion of gonadotropins", "Adrenocorticotropic hormone deficiency", "ACTH deficiency", "Thyroid-stimulating hormone deficiency", "TSH deficiency", "Growth hormone deficiency", "GH deficiency", "GHD", "CGHD", "AGHD", "Prolactin deficiency", "PRL deficiency" | 462 462 trials 179 / 102 / 139 / 68 💬 | 346 346 drugs [ 45 45 drugs ] | 41 41 genes 80 pathways | (1) [Disease ID 72-78 total] 17,069 patients (2) 18,653 patients Age distribution💬 | Pediatric diseases |
79 | Homozygous familial hypercholesterolemia | 128 128 trials 74 / 43 / 81 / 15 💬 | 105 105 drugs [ 29 29 drugs ] | 8 8 genes 15 pathways | (1) 140 patients (2) 352 patients Age distribution💬 | Pediatric diseases |
80 | Resistance to thyroid hormone "Syndrome of resistance to thyroid hormone", "Thyroid hormone insensitivity syndrome", "Refetoff syndrome" | 0 - | 0 - | 0 - | (1) About 3,000 patients (By the research group) (2) 43 patients Age distribution💬 | Pediatric diseases |
81 | Congenital adrenal hyperplasia "Congenital adrenal enzyme deficiency", "Congenial adrenal cortex enzyme deficiency", "Congenital Lipoid Adrenal Hyperplasia", "3β-Hydroxysteroid Dehydrogenase Deficiency", "21-Hydroxylase deficiency", "11β-Hydroxylase deficiency", "17α-Hydroxylase deficiency", "P450 oxidoreductase deficiency", "Aldosterone synthase deficiency" | 65 65 trials 34 / 35 / 22 / 7 💬 | 77 77 drugs [ 20 20 drugs ] | 11 11 genes 65 pathways | (1) About 1,800 patients (2) 864 patients Age distribution💬 | Pediatric diseases |
82 | Congenital adrenal hypoplasia "DAX-1 deficiency", "Steroidogenic factor-1 deficiency", "SF-1 deficiency", "SF-1/Ad4BP deficiency", "IMAGe syndrome" | 0 - | 0 - | 0 - | (1) About 1,000 patients (2) 49 patients Age distribution💬 | Pediatric diseases |
83 | Addison disease "Primary chronic adrenocortical insufficiency", "Autoimmune polyglandular syndrome", "Hypoparathyroidism-Addison-Monilia syndrome", "HAM syndrome", "Schmidt syndrome" | 20 20 trials 6 / 4 / 3 / 5 💬 | 42 42 drugs [ 13 13 drugs ] | 6 6 genes 17 pathways | (1) About 1,000 patients (By the research group) (2) 329 patients Age distribution💬 | Pediatric diseases |
84 | Sarcoidosis | 143 143 trials 56 / 60 / 28 / 28 💬 | 221 221 drugs [ 79 79 drugs ] | 82 82 genes 165 pathways | (1) 26,763 patients (2) 16,138 patients Age distribution💬 | |
85 | Idiopathic interstitial pneumonia "IIPs", "Idiopathic pulmonary fibrosis", "IPF", "Usual interstitial pneumonia", "UIP", "Non-specific interstitial pneumonia", "NSIP", "Acute interstitial pneumonia", "AIP", "Diffuse alveolar damage", "DAD", "COP", "Organizing pneumonia", "OP", "Desquamative interstitial pneumonia", "DIP", "Respiratory bronchiolitis - associated interstitial lung disease", "RB-ILD", "Lymphocytic interstitial pneumonia", "LIP" | 514 514 trials 228 / 208 / 116 / 64 💬 | 377 377 drugs [ 108 108 drugs ] | 97 97 genes 204 pathways | (1) More than about 15,000 patients (Medical care eligibility certificate holders in fiscal year 2,014: 8,846 patients) (2) 17,589 patients Age distribution💬 | Biobank Pediatric diseases |
86 | Pulmonary arterial hypertension "PAH", "IPAH", "HPAH", "Eisenmenger syndrome" | 1,083 1,083 trials 514 / 272 / 389 / 187 💬 | 667 667 drugs [ 122 122 drugs ] | 98 98 genes 185 pathways | (1) 2,299 patients (2) 4,230 patients Age distribution💬 | Pediatric diseases |
87 | Pulmonary veno-occlusive disease "Pulmonary capillary hemangiomatosis", "PVOD", "PCH" | 3 3 trials 1 / 1 / 0 / 0 💬 | 4 4 drugs [ 3 3 drugs ] | 4 4 genes 43 pathways | (1) About 100 patients (2) 25 patients Age distribution💬 | |
88 | Chronic thromboembolic pulmonary hypertension "CTEPH", "Idiopathic chronic pulmonary thromboembolism" | 145 145 trials 102 / 53 / 63 / 21 💬 | 112 112 drugs [ 22 22 drugs ] | 13 13 genes 52 pathways | (1) 1,810 patients (2) 4,608 patients Age distribution💬 | Biobank Animal model |
89 | Lymphangioleiomyomatosis "LAM" | 38 38 trials 14 / 17 / 8 / 2 💬 | 42 42 drugs [ 19 19 drugs ] | 26 26 genes 134 pathways | (1) 689 patients (2) 885 patients Age distribution💬 | Pediatric diseases |
90 | Retinitis pigmentosa "Rod dystrophy", "Rod-Cone Dystrophy" | 103 103 trials 91 / 56 / 22 / 10 💬 | 158 158 drugs [ 42 42 drugs ] | 52 52 genes 107 pathways | (1) 27,158 patients (2) 23,979 patients Age distribution💬 | Biobank |
91 | Budd-Chiari syndrome | 3 3 trials 0 / 0 / 0 / 1 💬 | 4 4 drugs [ 3 3 drugs ] | 2 2 genes 8 pathways | (1) 293 patients (2) 225 patients Age distribution💬 | Pediatric diseases |
92 | Idiopathic portal hypertension "Banti syndrome" | 0 - | 0 - | 0 - | (1) About 1,000 patients (2) 312 patients Age distribution💬 | Pediatric diseases |
93 | Primary biliary cholangitis "Primary biliary cirrhosis", "PBC" | 230 230 trials 190 / 110 / 75 / 60 💬 | 215 215 drugs [ 51 51 drugs ] | 34 34 genes 107 pathways | (1) 19,701 patients (2) 17,993 patients Age distribution💬 | |
94 | Primary sclerosing cholangitis "PSC" | 134 134 trials 68 / 57 / 46 / 10 💬 | 105 105 drugs [ 37 37 drugs ] | 18 18 genes 131 pathways | (1) About 400 patients (2) 1,010 patients Age distribution💬 | Pediatric diseases |
95 | Autoimmune hepatitis | 44 44 trials 11 / 19 / 11 / 8 💬 | 57 57 drugs [ 26 26 drugs ] | 18 18 genes 108 pathways | (1) About 10,000 patients (2) 6,962 patients Age distribution💬 | Pediatric diseases |
96 | Crohn disease "Terminal ileitis" | 2,209 2,209 trials 1302 / 711 / 873 / 391 💬 | 1,276 1,276 drugs [ 240 240 drugs ] | 166 166 genes 210 pathways | (1) 36,418 patients (2) 47,633 patients Age distribution💬 | Pediatric diseases |
97 | Ulcerative colitis | 2,269 2,269 trials 1401 / 847 / 954 / 366 💬 | 1,331 1,331 drugs [ 241 241 drugs ] | 114 114 genes 181 pathways | (1) 143,733 patients (2) 140,574 patients Age distribution💬 | Pediatric diseases |
98 | Eosinophilic gastrointestinal disease "Eosinophilic gastroenteritis", "Eosinophilic esophagitis", "Eosinophilic colitis", "Eosinophilic gastro-intestinal disorder", "EGID", "Neonatal food-protein induced enterocolitis", "N-FPIES" | 128 128 trials 60 / 56 / 56 / 16 💬 | 147 147 drugs [ 40 40 drugs ] | 34 34 genes 132 pathways | (1) About 5,000 patients (By the research group) (2) 1,144 patients Age distribution💬 | Pediatric diseases |
99 | Chronic intestinal pseudo-obstruction "Chronic idiopathic pseudo-bowel obstruction", "Chronic Idiopathic Intestinal Pseudo-Obstruction", "CIIP" | 3 3 trials 0 / 3 / 0 / 0 💬 | 6 6 drugs [ 1 1 drug ] | 0 - | (1) Child case: 100 patients, Adult case: 1,300 patients (2) 165 patients Age distribution💬 | Pediatric diseases |
100 | Megacystis microcolon intestinal hypoperistalsis syndrome "MMIHS", "Huge bladder short and small colon intestinal peristalsis deficiency" | 0 - | 0 - | 0 - | (1) Less than 100 patients (By the research group) (2) 1 patient Age distribution💬 | Pediatric diseases |
101 | Congenital isolated hypoganglionosis "Intestinal ganglion cells insignificant disease" | 0 - | 0 - | 0 - | (1) About 100 patients (By the research group) (2) 12 patients Age distribution💬 | Pediatric diseases |
102 | Rubinstein-Taybi syndrome "RSTS" | 3 3 trials 0 / 2 / 0 / 0 💬 | 8 8 drugs [ 1 1 drug ] | 7 7 genes 17 pathways | (1) About 200 patients (By the research group) (2) 9 patients Age distribution💬 | Biobank Pediatric diseases |
103 | Cardio-facio-cutaneous syndrome "CFC syndrome" | 0 - | 0 - | 0 - | (1) About 200 patients (By the research group) (2) 6 patients Age distribution💬 | Pediatric diseases |
104 | Costello syndrome | 0 - | 0 - | 0 - | (1) About 100 patients (By the research group) (2) 8 patients Age distribution💬 | Pediatric diseases |
105 | CHARGE syndrome | 0 - | 0 - | 0 - | (1) About 5,000 patients (By the research group) (2) 17 patients Age distribution💬 | Pediatric diseases |
106 | Cryopyrin-associated periodic syndrome "Cryopyrin associated periodic fever syndrome", "Familial cold autoinflammatory syndrome", "FCAS", "Mucke-Wells syndrome", "MWS", "Chronic infantile neurologic cutaneous, and articular syndrome", "CINCA syndrome", "Neonatal onset multisystem inflammatory disease", "NOMID" | 39 39 trials 28 / 11 / 13 / 5 💬 | 23 23 drugs [ 4 4 drugs ] | 4 4 genes 46 pathways | (1) About 100 patients (By the research group) (2) 74 patients Age distribution💬 | Pediatric diseases |
107 | Juvenile idiopathic arthritis [Systemic juvenile idiopathic arthritis (~Mar 2018)] "Systemic-onset juvenile idiopathic arthritis", "JIA", "SJIA" | 151 151 trials 80 / 34 / 50 / 28 💬 | 75 75 drugs [ 13 13 drugs ] | 16 16 genes 90 pathways | (1) About 8,000 patients (2) 743 patients Age distribution💬 | Pediatric diseases |
108 | TNF receptor-associated periodic syndrome | 4 4 trials 5 / 1 / 2 / 1 💬 | 7 7 drugs [ 1 1 drug ] | 1 1 gene 42 pathways | (1) Less than 100 patients (By the research group) (2) 30 patients Age distribution💬 | Pediatric diseases |
109 | Atypical hemolytic uremic syndrome "aHUS" | 95 95 trials 85 / 36 / 36 / 20 💬 | 27 27 drugs [ 5 5 drugs ] | 2 2 genes 9 pathways | (1) Less than 200 patients (By the research group) (2) 90 patients Age distribution💬 | Pediatric diseases |
110 | Blau syndrome "Early-onset sarcoidosis", "Systemic granulomatous diseases" | 0 - | 0 - | 0 - | (1) Less than 100 patients (By the research group) (2) 20 patients Age distribution💬 | Pediatric diseases |
111 | Congenital myopathy "Nemaline myopathy", "Central core disease", "Minicore myopathy", "Myotubular myopathy", "Centronuclear myopathy", "Congenital fiber-type disproportion myopathy" | 7 7 trials 9 / 6 / 1 / 2 💬 | 13 13 drugs [ 4 4 drugs ] | 1 1 gene 8 pathways | (1) About 1,000 patients (2) 316 patients Age distribution💬 | Biobank Pediatric diseases |
112 | Marinesco-Sjogren syndrome "Hereditary cerebellar ataxia-childhood cataracts" | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) 5 patients Age distribution💬 | Biobank |
113 | Muscular dystrophy "Dystrophinopathies", "Myotilinopathy", "Laminopathy", "Caveolinopathy", "LGMD1C", "Desminopathy", "Sarcoglycanopathy", "α-dystroglycanopathy", "FCMD", "Walker-Warburg syndrome", "Muscle-eye-brain disease", "Myotonic dystrophy", "Integrin α7 deficient CMD", "Rigid spine syndrome" | 567 567 trials 431 / 251 / 233 / 72 💬 | 442 442 drugs [ 93 93 drugs ] | 55 55 genes 151 pathways | (1) About 25,400 patients (2) 5,056 patients Age distribution💬 | Biobank Animal model Pediatric diseases |
114 | Non-dystrophic myotonia syndrome "Non-dystrophic Myotonia", "Myotonia congenita", "Thomsen disease", "Becker disease", "Paramyotonia congenita", "Sodium channel myotonia" | 10 10 trials 1 / 3 / 3 / 0 💬 | 14 14 drugs [ 5 5 drugs ] | 18 18 genes 10 pathways | (1) About 1,000 patients (2) 20 patients Age distribution💬 | |
115 | Hereditary periodic paralysis "Hereditary Hypokalemic Periodic Paralysis", "Andersen-Tawil syndrome", "Hereditary Hyperkalemic Periodic Paralysis" | 1 1 trial 1 / 0 / 0 / 0 💬 | 2 2 drugs [ 2 2 drugs ] | 13 13 genes 7 pathways | (1) About 1,000 patients (2) 59 patients Age distribution💬 | |
116 | Atopic myelitis "Idiopathic eosinophilic myelitis" | 0 - | 0 - | 0 - | (1) About 1,000 patients (2) 40 patients Age distribution💬 | |
117 | Syringomyelia | 2 2 trials 0 / 2 / 0 / 0 💬 | 4 4 drugs [ 0 - ] | 0 - | (1) About 3,000 patients (2) 626 patients Age distribution💬 | Pediatric diseases |
118 | Myelomeningocele "Myeloschisis", "Myelocele", "Myelocystocele", "Syringomyelocele" | 9 9 trials 1 / 1 / 0 / 1 💬 | 15 15 drugs [ 7 7 drugs ] | 8 8 genes 11 pathways | (1) 5.0~6.0 cases occur per 10,000 born (500~600 child patients are born per year) (2) 87 patients Age distribution💬 | Pediatric diseases |
119 | Isaacs syndrome "Morvan syndrome", "Morvan fibrillary chorea", "Anti-VGKC antibody-associated limbic encephalitis" | 0 - | 0 - | 0 - | (1) About 100 patients (2) 108 patients Age distribution💬 | Pediatric diseases |
120 | Hereditary dystonia "DYT1 dystonia", "DYT2 dystonia", "DYT3 dystonia", "X-linked dystonia-parkinsonism", "Lubag", "DYT4 dystonia", "DYT5 dystonia", "DYT5a dystonia", "DYT5b dystonia", "Segawa syndrome", "Dopa-responsive dystonia", "DYT6 dystonia", "DYT7 dystonia", "DYT8 dystonia", "Paroxysmal nonkinesigenic dyskinesia 1", "PNKD1", "DYT9 dystonia", "Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity", "Paroxysmal choreoathetosis and episodic ataxia and spasticity", "DYT10 dystonia", "Episodic kinesigenic dyskinesia 1", "EKD1", "DYT11 dystonia", "Myoclonus-dystonia syndrome", "DYT12 dystonia", "Rapid-onset dystonia-parkinsonism", "Alternating hemiplegia of childhood", "Cerebellar ataxia, areflexia, pes cavus, optic atropy, and sensorineural hearing loss", "CAPOS", "DYT13 dystonia", "DYT14 dystonia", "SS", "DRD", "DYT15 dystonia", "DYT16 dystonia", "DYT17 dystonia", "DYT18 dystonia", "Paroxysmal execise-induced dyskinesia", "DYT19 dystonia", "Episodic kinesigenic dyskinesia 2", "DYT20 dystonia", "Paroxysmal nonkinesigenic dyskinesia 2", "PNKD2", "Neurodegeneration with Brain Iron Accumulation 1", "Pantothenate kinase-associated neurodegeneration", "PKAN", "NBIA1", "Hallervorden-Spatz syndrome", "Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, pallidal degeneration", "Neurodegeneration with Brain Iron Accumulation 2", "Infantile neuroaxonal dystrophy", "INAD", "NBIA2", "Karak syndrome", "Neurodegeneration with Brain Iron Accumulation 3", "Neuroferritinopathy", "NBIA3", "Neurodegeneration with Brain Iron Accumulation 4", "Aceruloplasminemia", "Hereditary ceruloplasmin deficiency", "NBIA4", "Neurodegeneration with Brain Iron Accumulation 5", "NBIA5", "Beta-propeller protein-associated neurodegeneration", "BPAN", "Fatty Acid Hydroxylase-associated neurodegeneration", "Dysmyelinating leukodystrophy and spastic paraparasis with or without dystonia, spastic paraplegia 35" | 25 25 trials 11 / 3 / 17 / 3 💬 | 22 22 drugs [ 4 4 drugs ] | 2 2 genes 2 pathways | (1) About 500 patients (2) 103 patients Age distribution💬 | Pediatric diseases |
121 | Neuroferritinopathy | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) 2 patients Age distribution💬 | |
122 | Superficial siderosis "Brain table hemosiderosis" | 3 3 trials 0 / 0 / 0 / 0 💬 | 7 7 drugs [ 2 2 drugs ] | 0 - | (1) Less than 100 patients (2) 202 patients Age distribution💬 | |
123 | Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy "CARASIL", "Cerebral autosomal recessive arteriopathy with baldness and degenerative spondylosis", "Autosomal recessive leukoencephalopathy with baldness and degenerative spondylosis", "Cerebral autosomal recessive arteriopathy", "Autosomal recessive leukoencephalopathy" | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) 7 patients Age distribution💬 | |
124 | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy "CADASIL", "Autosomal dominant cerebral artery disease with subcortical infarct and leukoencephalopathy", "Autosomal dominant cerebral artery disease" | 11 11 trials 10 / 7 / 2 / 2 💬 | 13 13 drugs [ 4 4 drugs ] | 3 3 genes 11 pathways | (1) About 200 patients (2) 156 patients Age distribution💬 | |
125 | Hereditary diffuse leukoencephalopathy with spheroid "HDLS", "Hereditary diffuse leukoencephalopathy" | 1 1 trial 0 / 1 / 0 / 0 💬 | 9 9 drugs [ 1 1 drug ] | 0 - | (1) Less than 100 patients (2) 65 patients Age distribution💬 | |
126 | Perry syndrome | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) 4 patients Age distribution💬 | |
127 | Frontotemporal lobar degeneration "Frontotemporal dementia", "Semantic dementia" | 74 74 trials 24 / 26 / 27 / 8 💬 | 83 83 drugs [ 28 28 drugs ] | 29 29 genes 99 pathways | (1) About 12,000 patients (2) 1,287 patients Age distribution💬 | |
128 | Bickerstaff brainstem encephalitis | 0 - | 0 - | 0 - | (1) Occurrence: About 100 patients per year (2) 103 patients Age distribution💬 | |
129 | Acute encephalopathy with biphasic seizures and late reduced diffusion "Epilepticus type biphasic acute encphalopathy", "Epilepticus type acute encphalopathy" | 1 1 trial 0 / 1 / 0 / 0 💬 | 1 1 drug [ 1 1 drug ] | 0 - | (1) About 2,000~7,800 patients (Morbidity rate: 100~200 patients per year) (2) 48 patients Age distribution💬 | Pediatric diseases |
130 | Congenital insensitivity to pain with anhydrosis "CIPA", "Hereditary sensory and autonomic neuropathy type IV", "HSAN4", "Hereditary sensory and autonomic neuropathy type V", "HSAN5" | 0 - | 0 - | 0 - | (1) About 200~300 patients (2) 39 patients Age distribution💬 | Pediatric diseases |
131 | Alexander disease | 1 1 trial 1 / 1 / 1 / 0 💬 | 3 3 drugs [ 1 1 drug ] | 0 - | (1) Less than 100 patients (2) 43 patients Age distribution💬 | Pediatric diseases |
132 | Congenital supranuclear bulbar palsy "Congenital suprabulbar paresis", "Worcester drought syndrome", "Worster-Drought syndrome" | 0 - | 0 - | 0 - | (1) About 100 patients (2) 8 patients Age distribution💬 | |
133 | Moebius syndrome "Mobius syndrome", "Möbius syndrome" | 0 - | 0 - | 0 - | (1) About 1,000 patients (2) 11 patients Age distribution💬 | Pediatric diseases |
134 | Septo-optic dysplasia "De Morsier syndrome" | 1 1 trial 0 / 0 / 0 / 1 💬 | 1 1 drug [ 0 - ] | 0 - | (1) About 500 patients (2) 11 patients Age distribution💬 | Pediatric diseases |
135 | Aicardi syndrome | 1 1 trial 0 / 1 / 0 / 0 💬 | 9 9 drugs [ 3 3 drugs ] | 0 - | (1) Less than 100 patients (2) 14 patients Age distribution💬 | Pediatric diseases |
136 | Hemimegalencephaly "Unilateral megalencephaly" | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) 23 patients Age distribution💬 | |
137 | Focal cortical dysplasia "FCD" | 8 8 trials 0 / 6 / 0 / 0 💬 | 4 4 drugs [ 2 2 drugs ] | 1 1 gene 50 pathways | (1) A few thousand patients (2) 70 patients Age distribution💬 | |
138 | Nerve cell migration disorder "Lissencephaly", "Neuronal migration defect", "Ectopic gray matter", "Polymicrogyria", "Cortical dysplasia with cobblestone appearance", "Schizencephaly", "Porencephaly", "Miller-Dieker syndrome" | 0 - | 0 - | 0 - | (1) About 1,000 patients (2) 47 patients Age distribution💬 | Pediatric diseases |
139 | Congenital cerebral hypomyelination "Congenital cerebral white matter aplasia", "Pelizaeus-Merzbacher disease", "Pelizaeus-Merzbacher-like disease 1", "Pelizaeus-Merzbacher-like disease type 1", "Hypomyelination with atrophy of the basal ganglia and cerebellum", "18q-syndrome", "Chromosome 18q deletion syndrome", "Allan-Herndon-Dudley syndrome", "Mitochondrial Hsp60 chaperonopathy", "Salla disease", "Diffuse cerebral hypomyelination with cerebellar atrophy and hypoplasia of the corpus callosum", "Hypomyelination and congenital cataract", "Ataxia, delayed dentition, and hypomyelination", "Peripheral demyelinating neuropathy", "Central dysmyelinating leukodystrophy", "Waardenburg syndrome", "Hirschsprung disease" | 10 10 trials 1 / 7 / 0 / 0 💬 | 7 7 drugs [ 2 2 drugs ] | 2 2 genes 2 pathways | (1) About 200 patients (2) 32 patients Age distribution💬 | Pediatric diseases |
140 | Dorabe syndrome "Dravet syndrome" | 83 83 trials 59 / 21 / 57 / 13 💬 | 54 54 drugs [ 13 13 drugs ] | 48 48 genes 62 pathways | (1) About 3,000 patients (2) 55 patients Age distribution💬 | Pediatric diseases |
141 | Mesial temporal lobe epilepsy with hippocampal sclerosis "Medial temporal lobe epilepsy with hippocampal sclerosis", "Mesial temporal lobe epilepsy with bilateral hippocampal sclerosis", "Medial temporal lobe epilepsy" | 0 - | 0 - | 0 - | (1) About 5,000 patients (2) 67 patients Age distribution💬 | |
142 | Myoclonic absence epilepsy | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) 3 patients Age distribution💬 | |
143 | Epilepsy with myoclonic-atonic seizure "Epilepsy with myoclonic cataplexy" | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) 21 patients Age distribution💬 | |
144 | Lennox-Gastaut syndrome | 80 80 trials 54 / 17 / 54 / 12 💬 | 63 63 drugs [ 11 11 drugs ] | 49 49 genes 59 pathways | (1) [Disease ID 144-148 total] About 4,300 patients (2) 241 patients Age distribution💬 | Pediatric diseases |
145 | West syndrome "Infantile spasm" | 39 39 trials 15 / 15 / 15 / 9 💬 | 50 50 drugs [ 13 13 drugs ] | 27 27 genes 24 pathways | (1) [Disease ID 144-148 total] About 4,300 patients (2) 168 patients Age distribution💬 | Pediatric diseases |
146 | Ohtahara syndrome "Early infantile epileptic encephalopathy with suppression burst" | 0 - | 0 - | 0 - | (1) [Disease ID 144-148 total] About 4,300 patients (2) 20 patients Age distribution💬 | |
147 | Early myoclonic encephalopathy | 0 - | 0 - | 0 - | (1) [Disease ID 144-148 total] About 4,300 patients (2) 11 patients Age distribution💬 | |
148 | Epilepsy of infancy with migrating focal seizure "Infant epilepsy with migratory focus seizure", "Migrating partial seizures in infancy", "Infant epilepsy" | 0 - | 0 - | 0 - | (1) [Disease ID 144-148 total] About 4,300 patients (2) 21 patients Age distribution💬 | |
149 | Hemiconvulsion hemiplegia epilepsy syndrome "One side convulsions", "Hemiplegia", "Epilepsy syndrome" | 22 22 trials 3 / 4 / 7 / 1 💬 | 33 33 drugs [ 12 12 drugs ] | 13 13 genes 17 pathways | (1) Less than 100 patients (2) 24 patients Age distribution💬 | |
150 | Ring chromosome 20 epilepsy syndrome "Ring chromosome 20 syndrome" | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) 13 patients Age distribution💬 | Pediatric diseases |
151 | Rasmussen encephalitis | 2 2 trials 0 / 1 / 1 / 0 💬 | 4 4 drugs [ 2 2 drugs ] | 6 6 genes 84 pathways | (1) Less than 100 patients (2) 37 patients Age distribution💬 | Pediatric diseases |
152 | PCDH19 related syndrome "PCDH19 Epilepsy", "Epilepsy and mental retardation limited to females", "PCDH19 female pediatric epilepsy", "PCDH19-related epilepsy", "Protocadherin 19 (PCDH19)-related epilepsy" | 9 9 trials 5 / 5 / 4 / 1 💬 | 7 7 drugs [ 1 1 drug ] | 16 16 genes 7 pathways | (1) Less than 100 patients (2) 12 patients Age distribution💬 | |
153 | Acute encephalitis with refractory, repetitive partial seizure repetitive partial seizure", "AERRPS", "Refractory frequent partial seizures intussusception acute encephalitis", "Febrile infection related epilepsy syndrome", "FIRES", "New onset refractory status epilepsy syndrome", "NORSE syndrome" | 0 - | 0 - | 0 - | (1) About 100 patients (2) 41 patients Age distribution💬 | Pediatric diseases |
154 | Epilepsy with continuous spikes and waves during slow sleep "Epileptic encephalopathy with continuous spike-and-wave during sleep" | 1 1 trial 0 / 1 / 0 / 0 💬 | 1 1 drug [ 0 - ] | 0 - | (1) [Disease ID 154-155 total] About 400 patients (2) 32 patients Age distribution💬 | |
155 | Acquired aphasia with convulsive disorder "Landau-Kleffner syndrome" | 1 1 trial 0 / 1 / 1 / 0 💬 | 2 2 drugs [ 2 2 drugs ] | 29 29 genes 14 pathways | (1) [Disease ID 154-155 total] About 400 patients (2) 7 patients Age distribution💬 | |
156 | Rett syndrome | 36 36 trials 8 / 23 / 11 / 1 💬 | 49 49 drugs [ 19 19 drugs ] | 77 77 genes 112 pathways | (1) About 1,000 patients (2) 80 patients Age distribution💬 | Animal model Pediatric diseases |
157 | Sturge-Weber syndrome "Síndrome de Sturge-Weber" | 8 8 trials 3 / 5 / 1 / 0 💬 | 11 11 drugs [ 4 4 drugs ] | 5 5 genes 62 pathways | (1) About 1,000 patients (2) 79 patients Age distribution💬 | Pediatric diseases |
158 | Tuberous sclerosis "Tuberous sclerosis complex" | 100 100 trials 59 / 38 / 49 / 16 💬 | 62 62 drugs [ 16 16 drugs ] | 35 35 genes 115 pathways | (1) About 4,000~12,000 patients (2) 880 patients Age distribution💬 | Biobank Pediatric diseases |
159 | Xeroderma pigmentosum "XP" | 5 5 trials 1 / 1 / 1 / 0 💬 | 13 13 drugs [ 4 4 drugs ] | 4 4 genes 13 pathways | (1) About 300~600 patients (2) 80 patients Age distribution💬 | Biobank Pediatric diseases |
160 | Congenital ichthyosis "Keratinopathic ichthyosis", "Epidermolytic ichthyosis", "Harlequin ichthyosis", "Congenital Ichthyosiform Erythroderma", "Foliate ichthyosis", "Ichthyosis syndrome", "Netherton syndrome", "Sjogren-Larsson syndrome", "Sjögren-Larsson syndrome", "Keratitis-ichtyosis-deafness syndrome", "Dorfman-Chanarin syndrome", "Neutral lipid storage disease", "NLSD", "Multiple sulfatase deficiency", "Austin disease", "Recessive X-linked ichthyosis", "RXLI", "X-linked recessive ichthyosis", "Ichthyosis, brittle hair, impaired intelligence, decreased fertility and short stature", "IBID", "Trichothiodystrophy", "Follicular ichthyosis", "Congenital hemidysplasia, ichthyosiform erythroderma or nevus, and limb defects syndrome", "CHILD syndrome", "Conradi-Hunermann-Happle syndrome", "Conradi-Hünermann-Happle syndrome", "CHHS" | 32 32 trials 18 / 15 / 9 / 4 💬 | 62 62 drugs [ 18 18 drugs ] | 15 15 genes 107 pathways | (1) About 200 patients (2) 80 patients Age distribution💬 | Biobank Pediatric diseases |
161 | Familial benign chronic pemphigus "Benign familial pemphigus", "Hailey-Hailey disease" | 4 4 trials 2 / 2 / 0 / 0 💬 | 8 8 drugs [ 3 3 drugs ] | 1 1 gene 22 pathways | (1) About 300 patients (2) 60 patients Age distribution💬 | |
162 | Pemphigoid "Epidermolysis bullosa acquisita" | 70 70 trials 24 / 33 / 14 / 7 💬 | 117 117 drugs [ 46 46 drugs ] | 30 30 genes 128 pathways | (1) About 7,100 patients (Pemphigoid: About 6,850 patients、Epidermolysis bullosa acquisita: About 250 patients) (2) 3,965 patients Age distribution💬 | |
163 | Idiopathic pure sudomotor failure "Idiopathic acquired systemic anhidrosis", "Acquired idiopathic generalized anhidrosis", "AIGA", "Idiopathic segmental anhidrosis", "IPSF", "Sweat gland failure" | 0 - | 0 - | 0 - | (1) About 100 patients~200 patients (2) 433 patients Age distribution💬 | |
164 | Oculocutaneous albinism "Hermansky-Pudlak syndrome", "Chediak-Higashi syndrome", "Griscelli syndrome" | 15 15 trials 3 / 9 / 1 / 0 💬 | 57 57 drugs [ 34 34 drugs ] | 34 34 genes 136 pathways | (1) About 5,000 patients (2,800~11,200 patients) (2) 23 patients Age distribution💬 | Pediatric diseases |
165 | Pachydermoperiostosis | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) 17 patients Age distribution💬 | Pediatric diseases |
166 | Pseudoxanthoma elasticum "PXE" | 11 11 trials 1 / 8 / 2 / 1 💬 | 23 23 drugs [ 6 6 drugs ] | 5 5 genes 26 pathways | (1) About 300 patients (2) 101 patients Age distribution💬 | |
167 | Marfan syndrome | 19 19 trials 15 / 6 / 12 / 4 💬 | 38 38 drugs [ 10 10 drugs ] | 10 10 genes 49 pathways | (1) About 15,000~20,000 patients (2) 1,003 patients Age distribution💬 | Biobank Pediatric diseases |
168 | Ehlers-Danlos syndrome "EDS", "cEDS", "hEDS", "clEDS", "vEDS", "kEDS", "aEDS", "dEDS", "DDEDS" | 7 7 trials 0 / 1 / 2 / 1 💬 | 16 16 drugs [ 8 8 drugs ] | 9 9 genes 54 pathways | (1) About 20,000 patients (2) 165 patients Age distribution💬 | Biobank Animal model Pediatric diseases |
169 | Menkes disease | 6 6 trials 1 / 1 / 1 / 0 💬 | 6 6 drugs [ 3 3 drugs ] | 0 - | (1) Less than 100 patients (2) 1 patient Age distribution💬 | Biobank Pediatric diseases |
170 | Occipital horn syndrome | 1 1 trial 0 / 0 / 1 / 0 💬 | 3 3 drugs [ 2 2 drugs ] | 0 - | (1) Less than 100 patients (2) 1 patient Age distribution💬 | Pediatric diseases |
171 | Wilson disease | 50 50 trials 34 / 15 / 26 / 10 💬 | 59 59 drugs [ 17 17 drugs ] | 3 3 genes 28 pathways | (1) About 3,000 patients (2) 695 patients Age distribution💬 | Biobank Pediatric diseases |
172 | Hypophosphatasia | 32 32 trials 12 / 20 / 4 / 5 💬 | 18 18 drugs [ 4 4 drugs ] | 3 3 genes 6 pathways | (1) About 100~200 patients (2) 20 patients Age distribution💬 | Pediatric diseases |
173 | VATER syndrome "VATER association", "VACTERL association" | 0 - | 0 - | 0 - | (1) About 500 patients (2) 18 patients Age distribution💬 | Pediatric diseases |
174 | Nasu-Hakola disease "Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy", "PLOSL" | 0 - | 0 - | 0 - | (1) About 200 patients (2) 4 patients Age distribution💬 | |
175 | Weaver syndrome | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) - Age distribution💬 | Pediatric diseases |
176 | Coffin-Lowry syndrome | 0 - | 0 - | 0 - | (1) One patient per tens of thousand population (2) 4 patients Age distribution💬 | Pediatric diseases |
177 | Joubert syndrome related disorder [Arima syndrome (~Mar 2018)] "Joubert syndrome and related disorder", "Joubert syndrome", "JSRD", "Senior-Loken syndrome", "Senior-Løken syndrome", "COACH syndrome", "Orofaciodigital syndrome" | 1 1 trial 0 / 0 / 0 / 0 💬 | 1 1 drug [ 0 - ] | 0 - | (1) Less than 100 patients (2) 6 patients Age distribution💬 | Pediatric diseases |
178 | Mowat-Wilson syndrome | 0 - | 0 - | 0 - | (1) About 1,000 patients (2) 14 patients Age distribution💬 | Pediatric diseases |
179 | Williams syndrome | 4 4 trials 0 / 0 / 0 / 1 💬 | 13 13 drugs [ 7 7 drugs ] | 8 8 genes 32 pathways | (1) Occurrence: One patient per twenty thousand population (2) 46 patients Age distribution💬 | Pediatric diseases |
180 | ATR-X syndrome "Alpha-thalassemia mental retardation syndrome" | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) 8 patients Age distribution💬 | Pediatric diseases |
181 | Crouzon syndrome | 0 - | 0 - | 0 - | (1) [Disease ID 181-184 total] About 900 patients (2) 17 patients Age distribution💬 | Pediatric diseases |
182 | Apert syndrome | 0 - | 0 - | 0 - | (1) [Disease ID 181-184 total] About 900 patients (2) 8 patients Age distribution💬 | Pediatric diseases |
183 | Pfeiffer syndrome | 0 - | 0 - | 0 - | (1) [Disease ID 181-184 total] About 900 patients (2) 6 patients Age distribution💬 | Pediatric diseases |
184 | Antley-Bixler syndrome | 0 - | 0 - | 0 - | (1) [Disease ID 181-184 total] About 900 patients (2) 2 patients Age distribution💬 | Pediatric diseases |
185 | Coffin-Siris syndrome | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) 4 patients Age distribution💬 | Pediatric diseases |
186 | Rothmund-Thomson syndrome "RAPADILINO syndrome", "Baller-Gerold syndrome" | 1 1 trial 0 / 0 / 0 / 0 💬 | 2 2 drugs [ 1 1 drug ] | 0 - | (1) Less than 100 patients (2) 2 patients Age distribution💬 | |
187 | Kabuki syndrome | 2 2 trials 0 / 0 / 0 / 0 💬 | 7 7 drugs [ 2 2 drugs ] | 3 3 genes 15 pathways | (1) About 3,000~4,000 patients (2) 11 patients Age distribution💬 | Pediatric diseases |
188 | Polysplenia syndrome | 0 - | 0 - | 0 - | (1) [Disease ID 188-189 total] About 2,000 patients (2) 45 patients Age distribution💬 | Pediatric diseases |
189 | Asplenia syndrome | 0 - | 0 - | 0 - | (1) [Disease ID 188-189 total] About 2,000 patients (2) 75 patients Age distribution💬 | Pediatric diseases |
190 | Branchio-oto-renal syndrome "BOR syndrome" | 0 - | 0 - | 0 - | (1) About 300 patients (2) 6 patients Age distribution💬 | |
191 | Werner syndrome | 3 3 trials 2 / 1 / 0 / 0 💬 | 4 4 drugs [ 3 3 drugs ] | 1 1 gene 5 pathways | (1) About 2,000 patients (2) 114 patients Age distribution💬 | Biobank Pediatric diseases |
192 | Cockayne syndrome "CS" | 4 4 trials 1 / 3 / 0 / 0 💬 | 7 7 drugs [ 3 3 drugs ] | 1 1 gene 50 pathways | (1) Less than 100 patients (2) 7 patients Age distribution💬 | Biobank Pediatric diseases |
193 | Prader-Willi syndrome | 95 95 trials 31 / 36 / 40 / 13 💬 | 104 104 drugs [ 27 27 drugs ] | 50 50 genes 63 pathways | (1) About 1,000 patients (2) 167 patients Age distribution💬 | Pediatric diseases |
194 | Sotos syndrome | 0 - | 0 - | 0 - | (1) About 2,500 patients (2) 14 patients Age distribution💬 | Pediatric diseases |
195 | Noonan syndrome | 14 14 trials 0 / 3 / 6 / 0 💬 | 15 15 drugs [ 5 5 drugs ] | 2 2 genes 9 pathways | (1) About 600 patients (2) 39 patients Age distribution💬 | Pediatric diseases |
196 | Young-Simpson syndrome | 0 - | 0 - | 0 - | (1) About 100 patients (2) - Age distribution💬 | Pediatric diseases |
197 | 1p36 deletion syndrome | 0 - | 0 - | 0 - | (1) About 100 patients (2) 8 patients Age distribution💬 | Pediatric diseases |
198 | 4p deletion syndrome "4p-syndrome" | 0 - | 0 - | 0 - | (1) Less than about 1,000 patients (2) 5 patients Age distribution💬 | Pediatric diseases |
199 | 5p deletion syndrome "5p-syndrome" | 0 - | 0 - | 0 - | (1) Less than about 1,000 patients (One per fifty thousand born, probably less than 1,000 patients estimated) (2) 1 patient Age distribution💬 | Pediatric diseases |
200 | Paternal uniparental disomy of chromosome 14 "No. 14 chromosome father disomy syndrome", "Kagami-Ogata syndrome" | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) 6 patients Age distribution💬 | Pediatric diseases |
201 | Angelman syndrome | 19 19 trials 6 / 5 / 5 / 0 💬 | 30 30 drugs [ 7 7 drugs ] | 22 22 genes 20 pathways | (1) 500~1,000 patients (2) 27 patients Age distribution💬 | Pediatric diseases |
202 | Smith-Magenis syndrome | 10 10 trials 12 / 6 / 4 / 2 💬 | 10 10 drugs [ 4 4 drugs ] | 4 4 genes 6 pathways | (1) Less than 100 patients (2) 1 patient Age distribution💬 | Pediatric diseases |
203 | 22q11.2 deletion syndrome | 3 3 trials 1 / 0 / 0 / 0 💬 | 3 3 drugs [ 0 - ] | 0 - | (1) About 4,500 patients (2) 71 patients Age distribution💬 | Pediatric diseases |
204 | Emanuel syndrome "Derivative 22 syndrome" | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) 3 patients Age distribution💬 | Pediatric diseases |
205 | Fragile X syndrome related disease "Fragile X-associated tremor/ataxia syndrome", "FXTAS" | 3 3 trials 0 / 2 / 0 / 0 💬 | 3 3 drugs [ 2 2 drugs ] | 21 21 genes 25 pathways | (1) [Disease ID 205-206 total] Less than 100 patients (2) 5 patients Age distribution💬 | |
206 | Fragile X syndrome | 98 98 trials 31 / 46 / 14 / 7 💬 | 73 73 drugs [ 27 27 drugs ] | 46 46 genes 57 pathways | (1) [Disease ID 205-206 total] Less than 100 patients (2) 3 patients Age distribution💬 | Pediatric diseases |
207 | Persistent truncus arteriosus | 0 - | 0 - | 0 - | (1) About 500 patients (2) 29 patients Age distribution💬 | Pediatric diseases |
208 | Corrected transposition of great arteries | 0 - | 0 - | 0 - | (1) [Disease ID 208-209 total] About 900 patients (2) 172 patients Age distribution💬 | Pediatric diseases |
209 | Complete transposition of great vessel "Complete transposition of great arteries", "Complete TGA" | 0 - | 0 - | 0 - | (1) [Disease ID 208-209 total] About 900 patients (2) 211 patients Age distribution💬 | Pediatric diseases |
210 | Single Ventricle "SV", "Single ventricle heart defect", "Univentricular heart", "UVH", "Single ventricular circulation syndrome" | 47 47 trials 41 / 17 / 22 / 10 💬 | 54 54 drugs [ 23 23 drugs ] | 32 32 genes 66 pathways | (1) [Disease ID 210-213 total] About 3,500 patients (Patients of single ventricle heart defects) (2) 349 patients Age distribution💬 | Pediatric diseases |
211 | Hypoplastic left heart syndrome "HLHS" | 20 20 trials 11 / 9 / 0 / 0 💬 | 28 28 drugs [ 9 9 drugs ] | 5 5 genes 13 pathways | (1) [Disease ID 210-213 total] About 3,500 patients (Patients of single ventricle heart defects) (2) 37 patients Age distribution💬 | Pediatric diseases |
212 | Tricuspid atresia "TA" | 6 6 trials 2 / 2 / 0 / 0 💬 | 8 8 drugs [ 7 7 drugs ] | 8 8 genes 12 pathways | (1) [Disease ID 210-213 total] About 3,500 patients (Patients of single ventricle heart defects) (2) 161 patients Age distribution💬 | Pediatric diseases |
213 | Pulmonary atresia without ventricular septum defect "Pulmonary atresia with intact ventricular septum", "Pulmonary atresia" | 0 - | 0 - | 0 - | (1) [Disease ID 210-213 total] About 3,500 patients (Patients of single ventricle heart defects) (2) 105 patients Age distribution💬 | Pediatric diseases |
214 | Pulmonary atresia with ventricular septum defect "PAVSD", "Pulmonary atresia with ventricular septal defect", "Pulmonary atresia", "TFPA" | 2 2 trials 0 / 0 / 0 / 0 💬 | 4 4 drugs [ 4 4 drugs ] | 0 - | (1) [Disease ID 214-216 total] About 5,500 patients (Patients of tetralogy of Fallot related diseases) (2) 95 patients Age distribution💬 | Pediatric diseases |
215 | Tetralogy of Fallot "Fallot tetralogy" | 19 19 trials 2 / 3 / 1 / 1 💬 | 35 35 drugs [ 16 16 drugs ] | 16 16 genes 47 pathways | (1) [Disease ID 214-216 total] About 5,500 patients (Patients of tetralogy of Fallot related diseases) (2) 597 patients Age distribution💬 | Pediatric diseases |
216 | Double outlet right ventricle | 0 - | 0 - | 0 - | (1) [Disease ID 214-216 total] About 5,500 patients (Patients of tetralogy of Fallot related diseases) (2) 203 patients Age distribution💬 | Pediatric diseases |
217 | Ebstein disease "Ebstein malformation" | 0 - | 0 - | 0 - | (1) About 300 patients (2) 115 patients Age distribution💬 | Pediatric diseases |
218 | Alport syndrome | 16 16 trials 16 / 8 / 8 / 3 💬 | 24 24 drugs [ 11 11 drugs ] | 5 5 genes 27 pathways | (1) About 1,200 patients (2) 195 patients Age distribution💬 | Animal model Pediatric diseases |
219 | Galloway-Mowat syndrome | 0 - | 0 - | 0 - | (1) About 200 patients (2) - Age distribution💬 | Pediatric diseases |
220 | Rapidly progressive glomerulonephritis | 2 2 trials 0 / 1 / 2 / 0 💬 | 5 5 drugs [ 2 2 drugs ] | 1 1 gene 1 pathway | (1) About 3,800~5,800 patients in total estimated (2) 1,084 patients Age distribution💬 | Animal model Pediatric diseases |
221 | Anti-glomerular basement membrane disease | 1 1 trial 0 / 1 / 0 / 0 💬 | 3 3 drugs [ 1 1 drug ] | 0 - | (1) About 200~400 patients (2) 319 patients Age distribution💬 | Pediatric diseases |
222 | Primary nephrotic syndrome "Minimal change nephrotic syndrome", "MCNS", "Membranous nephropathy", "Focal segmental glomerulosclerosis", "FSGS", "Membranoproliferative glomerulonephritis", "MPGN" | 234 234 trials 103 / 100 / 49 / 38 💬 | 241 241 drugs [ 78 78 drugs ] | 59 59 genes 185 pathways | (1) About 16,000 patients (2) 12,018 patients Age distribution💬 | Pediatric diseases |
223 | Primary membranoproliferative glomerulonephritis "Dense deposit disease" | 18 18 trials 19 / 14 / 3 / 3 💬 | 14 14 drugs [ 7 7 drugs ] | 7 7 genes 14 pathways | (1) About 1,000 patients (2) 333 patients Age distribution💬 | Pediatric diseases |
224 | Purpura nephritis | 10 10 trials 2 / 3 / 0 / 1 💬 | 41 41 drugs [ 19 19 drugs ] | 15 15 genes 56 pathways | (1) 400~640 cases / year (2) 1,045 patients Age distribution💬 | Pediatric diseases |
225 | Congenital nephrogenic diabetes insipidus "Hereditary nephrogenic diabetes insipidus", "Nephrogenic diabetes insipidus" | 12 12 trials 7 / 4 / 1 / 1 💬 | 45 45 drugs [ 17 17 drugs ] | 30 30 genes 63 pathways | (1) About 200 patients (2) 48 patients Age distribution💬 | Pediatric diseases |
226 | Interstitial cystitis with Hunners ulcer "Interstitial cystitis" | 133 133 trials 46 / 49 / 25 / 16 💬 | 151 151 drugs [ 46 46 drugs ] | 48 48 genes 137 pathways | (1) About 2,000 patients (2) 863 patients Age distribution💬 | |
227 | Osler disease "Hereditary hemorrhagic telangiectasia", "Osler-Weber-Rendu disease" | 49 49 trials 21 / 30 / 11 / 4 💬 | 69 69 drugs [ 21 21 drugs ] | 23 23 genes 132 pathways | (1) About 10,000 patients (2) 802 patients Age distribution💬 | Pediatric diseases |
228 | Bronchiolitis obliterans "Obliterating bronchiolitis" | 92 92 trials 59 / 36 / 35 / 17 💬 | 125 125 drugs [ 34 34 drugs ] | 33 33 genes 152 pathways | (1) About 300~500 patients (2) 31 patients Age distribution💬 | Pediatric diseases |
229 | Autoimmune pulmonary alveolar proteinosis "Congenital pulmonary alveolar proteinosis", "Hereditary pulmonary alveolar proteinosis", "Pulmonary alveolar proteinosis", "PAP" | 35 35 trials 42 / 22 / 19 / 7 💬 | 30 30 drugs [ 8 8 drugs ] | 3 3 genes 12 pathways | (1) About 900 patients (Autoimmune and congenital pulmonary alveolar proteinoses) (2) 204 patients Age distribution💬 | Pediatric diseases |
230 | Alveolar hypoventilation syndrome "AHS", "Hypoventilation syndrome", "OHS", "CCHS", "Idiopathic central alveolar hypoventilation", "ICAH" | 8 8 trials 0 / 2 / 2 / 0 💬 | 11 11 drugs [ 5 5 drugs ] | 18 18 genes 27 pathways | (1) About 3,000 patients (2) 122 patients Age distribution💬 | Pediatric diseases |
231 | Alpha-1-antitrypsin deficiency "AATD" | 83 83 trials 63 / 56 / 31 / 12 💬 | 89 89 drugs [ 16 16 drugs ] | 35 35 genes 46 pathways | (1) Less than 100 patients (2) 14 patients Age distribution💬 | Pediatric diseases |
232 | Carney complex | 1 1 trial 0 / 1 / 0 / 0 💬 | 3 3 drugs [ 1 1 drug ] | 1 1 gene 29 pathways | (1) Less than 100 patients (2) 21 patients Age distribution💬 | |
233 | Wolfram syndrome "Diabetes Insipidus, Diabetes mellitus, optic atrophy, and deafness syndrome", "DIDMOAD syndrome" | 6 6 trials 6 / 5 / 2 / 1 💬 | 12 12 drugs [ 7 7 drugs ] | 11 11 genes 40 pathways | (1) About 200 patients (2) 9 patients Age distribution💬 | Pediatric diseases |
234 | Peroxisomal disease (except Adrenoleukodystrophy) "Peroxisomal disease", "Peroxisomal disorder", "Peroxisome biogenesis disorder", "PEX gene disorder", "Zellweger syndrome", "Neonatal adrenoleukodystrophy", "Rhizomelic chondrodysplasia punctata type 1", "RCDP type 1", "RCDP1", "Peroxisomal beta-oxidation enzyme deficiency", "Acyl-CoA oxidase deficiency", "AOX deficiency", "D-Bifunctional protein deficiency", "DBP deficiency", "Sterol carrier protein X deficiency", "SCPx deficiency", "2-methylacyl-CoA racemase deficiency", "Alpha-methylacyl-CoA racemase deficiency", "AMACR deficiency", "Refsum disease", "Plasmalogen biosynthesis enzyme deficiency", "Rhizomelic chondrodysplasia punctata type 2", "RCDP type 2", "RCDP2", "Rhizomelic chondrodysplasia punctata type 3", "RCDP type 3", "RCDP3", "Primary hyperoxaluria type 1", "PH1", "Acatalasemia", "Acatalasia", "Contiguous ABCD1/DXS1357E deletion syndrome", "CADDS" | 38 38 trials 30 / 20 / 18 / 5 💬 | 37 37 drugs [ 12 12 drugs ] | 12 12 genes 42 pathways | (1) Less than 100 patients (2) - Age distribution💬 | Pediatric diseases |
235 | Hypoparathyroidism "Accessory thyroid hypergasia disease" | 67 67 trials 28 / 18 / 23 / 15 💬 | 112 112 drugs [ 24 24 drugs ] | 4 4 genes 5 pathways | (1) About 900 patients (2) 307 patients Age distribution💬 | Pediatric diseases |
236 | Pseudohypoparathyroidism "PHP", "PHP1a", "PHP1b", "PHP1c", "PHP2" | 6 6 trials 0 / 4 / 0 / 1 💬 | 4 4 drugs [ 2 2 drugs ] | 20 20 genes 28 pathways | (1) About 400 patients (2) 105 patients Age distribution💬 | Pediatric diseases |
237 | ACTH unresponsiveness "Adrenocorticotropic hormone unresponsiveness", "Adrenocorticotropic hormone insensitivity", "Triple A syndrome", "Allgrove syndrome" | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) 10 patients Age distribution💬 | Pediatric diseases |
238 | Vitamin D-resistant rickets "Vitamin D-resistant osteomalacia", "FGF23-related hypophosphatemic disease", "FGF23-related hypophosphatemia", "VDRR", "VDRO" | 1 1 trial 0 / 0 / 1 / 0 💬 | 1 1 drug [ 0 - ] | 0 - | (1) 117 cases per year in Japan (95% CI 75-160) estimated by the national survey of the MHLW research group of abnormalities in hormonal signaling mechanisms (2) 342 patients Age distribution💬 | Pediatric diseases |
239 | Vitamin D-dependent rickets "Vitamin D-dependent osteomalacia", "VDDR", "VDDR1", "VDDR2", "VDDO" | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) 5 patients Age distribution💬 | Pediatric diseases |
240 | Phenylketonuria "PKU", "Phenylalanine hydroxylase deficiency", "PAH deficiency", "Tetrahydrobiopterin deficiency", "BH4 deficiency", "BH4 reactive hyper pheemia" | 125 125 trials 77 / 30 / 32 / 24 💬 | 95 95 drugs [ 11 11 drugs ] | 1 1 gene 5 pathways | (1) About 500 patients (2) 248 patients Age distribution💬 | Pediatric diseases |
241 | Hypertyrosinemia type I "Tyrosinemia type I", "Tyrosinemia I", "Hereditary tyrosinemia, Type I", "Fumarylacetoacetate hydrolase deficiency", "FAH deficiency" | 14 14 trials 4 / 1 / 1 / 1 💬 | 7 7 drugs [ 1 1 drug ] | 1 1 gene 5 pathways | (1) [Disease ID 241-243 total] Less than 100 patients (2) 2 patients Age distribution💬 | Pediatric diseases |
242 | Hypertyrosinemia type II "Tyrosinemia type II", "Tyrosinemia II", "Hereditary tyrosinemia, Type II" | 0 - | 0 - | 0 - | (1) [Disease ID 241-243 total] Less than 100 patients (2) - Age distribution💬 | Pediatric diseases |
243 | Hypertyrosinemia type III "High tyrosinemia", "Tyrosinemia type III", "Tyrosinemia III", "Hereditary tyrosinemia, Type III" | 0 - | 0 - | 0 - | (1) [Disease ID 241-243 total] Less than 100 patients (2) 1 patient Age distribution💬 | Pediatric diseases |
244 | Maple syrup urine disease "MSUD" | 1 1 trial 0 / 1 / 1 / 0 💬 | 1 1 drug [ 1 1 drug ] | 0 - | (1) About 100 patients (2) 12 patients Age distribution💬 | Pediatric diseases |
245 | Propionic acidemia | 9 9 trials 3 / 5 / 1 / 0 💬 | 15 15 drugs [ 3 3 drugs ] | 1 1 gene 6 pathways | (1) About 300 patients (2) 12 patients Age distribution💬 | Pediatric diseases |
246 | Methylmalonic acidemia | 14 14 trials 8 / 9 / 2 / 1 💬 | 22 22 drugs [ 2 2 drugs ] | 1 1 gene 6 pathways | (1) About 300 patients (2) 24 patients Age distribution💬 | Pediatric diseases |
247 | Isovaleric acidemia "Isovaleric aciduria", "Isovaleric acid CoA dehydrogenase deficiency" | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) 3 patients Age distribution💬 | Pediatric diseases |
248 | Glucose transporter type 1 deficiency "GLUT1 deficiency" | 30 30 trials 43 / 20 / 9 / 8 💬 | 9 9 drugs [ 1 1 drug ] | 0 - | (1) Less than 100 patients (2) 13 patients Age distribution💬 | Pediatric diseases |
249 | Glutaric acidemia type 1 | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) 3 patients Age distribution💬 | Pediatric diseases |
250 | Glutaric acidemia type 2 "Multiple acyl-CoA dehydrogenase deficiency", "Multiple acyl-CoA dehydrogenation deficiency", "MADD" | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) 6 patients Age distribution💬 | Pediatric diseases |
251 | Urea cycle disorder "N-acetylglutamate synthase deficiency", "NAGS deficiency", "Carbamoyl phosphate synthetase I deficiency", "CPS1 deficiency", "Ornithine transcarbamylase deficiency", "OTC deficiency", "Classic citrullinemia", "Citrullinemia type I", "Argininosuccinic aciduria", "Argininemia", "Hiperornitinemia-hiperamonemia-homocitrulinuria syndrome", "HHH syndrome" | 42 42 trials 37 / 25 / 4 / 7 💬 | 45 45 drugs [ 10 10 drugs ] | 4 4 genes 29 pathways | (1) OTC deficiency: About 500 patients; CPSI deficiency: About 100 patients; Argininosuccinic aciduria: About 100 patients; Other urea cycle disorders: Less than 100 patients; (2) 84 patients Age distribution💬 | Pediatric diseases |
252 | Lysinuric protein intolerance | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) 24 patients Age distribution💬 | Pediatric diseases |
253 | Congenital folate malabsorption "Hereditary folate malabsorption", "Folate malabsorption" | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) - Age distribution💬 | Pediatric diseases |
254 | Porphyria "CEP", "Erythropoietic protoporphyria", "EPP", "X-linked dominant protoporphyria", "XLDP", "PCT", "HEP", "AIP", "ADP", "VP", "Hereditary coproporphyria", "HCP" | 59 59 trials 32 / 17 / 28 / 6 💬 | 52 52 drugs [ 17 17 drugs ] | 17 17 genes 33 pathways | (1) About 200 patients (2) 41 patients Age distribution💬 | Pediatric diseases |
255 | Multiple carboxylase deficiency "Holocarboxylase synthetase deficiency", "HCS deficiency", "Biotinidase deficiency" | 1 1 trial 1 / 1 / 0 / 0 💬 | 1 1 drug [ 0 - ] | 0 - | (1) HCS deficiency: 1 / 1,000,000 occurrence in Japan; Biotinidase deficiency: a few cases reported; (2) 5 patients Age distribution💬 | Pediatric diseases |
256 | Muscle glycogenosis "Muscular glycogenosis", "Muscle glycogen storage disease", "Muscular glycogen storage disease", "Glycogen storage disease type 0", "GSD0", "Glycogen synthase deficiency", "Glycogen storage disease type II", "GSDII", "Pompe disease", "Alpha-1,4-glucosidase acid deficiency", "Glycogen storage disease type III", "GSDIII", "Cori disease", "Glycogen debranching enzyme deficiency", "Glycogen storage disease type IV", "GSDIV", "Andersen disease", "Glycogen-branching enzyme deficiency", "GBED", "Glycogen storage disease type V", "GSDV", "McArdle disease", "Muscle phosphorylase deficiency", "Muscular phosphorylase deficiency", "Glycogen storage disease type VII", "GSDVII", "Tarui disease", "Phosphofructokinase deficiency", "PFK deficiency", "Glycogen storage disease type IX", "GSDIX", "Phosphorylase kinase deficiency", "Phosphoglycerate kinase deficiency", "PGK deficiency", "Glycogen storage disease type X", "GSDX", "Phosphoglycerate mutase deficiency", "Glycogen storage diseass type XI", "GSDXI", "Kanno disease", "Lactate dehydrogenase deficiency", "Glycogen storage diseass type XII", "GSDXII", "Aldolase A deficiency", "Glycogen storage diseass type XIII", "GSDXIII", "Beta-enolase deficiency", "Glycogen storage diseass type XIV", "GSDXIV", "Phosphoglucomutase deficiency", "Glycogen storage diseass type XV", "GSDXV", "Glycogenin 1 deficiency" | 161 161 trials 98 / 59 / 58 / 31 💬 | 114 114 drugs [ 23 23 drugs ] | 26 26 genes 106 pathways | (1) About 3,000~6,000 patients estimated (2) 25 patients Age distribution💬 | Pediatric diseases |
257 | Hepatic glycogenosis "Liver glycogenosis", "Hepatic glycogen storage disease", "Liver glycogen storage disease", "Glycogen storage disease type I", "GSDI", "von Gierke disease", "Glucose-6-phosphatase deficiency", "G6Pase deficiency", "Glycogen storage disease type III", "GSDIII", "Cori disease", "Glycogen debranching enzyme deficiency", "Glycogen storage disease type IV", "GSDIV", "Andersen disease", "Glycogen-branching enzyme deficiency", "GBED", "Adult polyglucosan body disease", "Glycogen storage disease type VI", "GSDVI", "Hers disease", "Hepatic phosphorylase deficiency", "Liver phosphorylase deficiency", "Glycogen storage disease type IX", "GSDIX", "Phosphorylase kinase deficiency" | 10 10 trials 1 / 3 / 0 / 0 💬 | 19 19 drugs [ 6 6 drugs ] | 1 1 gene 6 pathways | (1) About 1,200 patients (2) 92 patients Age distribution💬 | Pediatric diseases |
258 | Galactose-1-phosphate uridylyltransferase deficiency "Galactose-1-phosphate uridyltransferase deficiency", "Galactosemia type 1", "GALT deficiency" | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) 2 patients Age distribution💬 | Pediatric diseases |
259 | Lecithin-cholesterol acyltransferase deficiency "LCAT deficiency", "Fish-eye disease" | 1 1 trial 0 / 0 / 0 / 0 💬 | 2 2 drugs [ 1 1 drug ] | 0 - | (1) Less than 100 patients (2) 4 patients Age distribution💬 | Pediatric diseases |
260 | Sitosterolemia | 13 13 trials 0 / 1 / 5 / 0 💬 | 13 13 drugs [ 4 4 drugs ] | 1 1 gene 1 pathway | (1) Less than 100 patients (2) 18 patients Age distribution💬 | Pediatric diseases |
261 | Tangier disease | 1 1 trial 0 / 0 / 0 / 0 💬 | 2 2 drugs [ 1 1 drug ] | 0 - | (1) Less than 100 patients (2) 8 patients Age distribution💬 | Pediatric diseases |
262 | Primary hyperchylomicronemia | 0 - | 0 - | 0 - | (1) About 300 patients (2) 31 patients Age distribution💬 | Pediatric diseases |
263 | Cerebrotendinous xanthomatosis "27-hydroxylase deficiency", "CYP27 deficiency" | 5 5 trials 0 / 1 / 2 / 0 💬 | 10 10 drugs [ 2 2 drugs ] | 2 2 genes 4 pathways | (1) Less than 100 patients (2) 44 patients Age distribution💬 | Pediatric diseases |
264 | Abetalipoproteinemia "Microsomal triglyceride transfer protein deficiency", "MTP deficiency" | 0 - | 0 - | 0 - | (1) Less than 100 patients (Only a few pedigrees in Japan since the first report in 1,983) (2) 5 patients Age distribution💬 | Pediatric diseases |
265 | Lipodystrophy "Berardinelli-Seip syndrome", "Lawrence syndrome", "Barraquer-Simons syndrome" | 109 109 trials 38 / 32 / 18 / 30 💬 | 164 164 drugs [ 59 59 drugs ] | 26 26 genes 94 pathways | (1) About 100 patients (2) 31 patients Age distribution💬 | Pediatric diseases |
266 | Familial mediterranean fever | 27 27 trials 1 / 7 / 9 / 1 💬 | 23 23 drugs [ 6 6 drugs ] | 14 14 genes 57 pathways | (1) About 300 patients (2) 471 patients Age distribution💬 | Pediatric diseases |
267 | Hyper-IgD syndrome "HIDS", "Mevalonate kinase deffiency", "Hyperimmunoglobulinemia D and periodic fever syndrome" | 11 11 trials 0 / 2 / 8 / 0 💬 | 6 6 drugs [ 1 1 drug ] | 1 1 gene 42 pathways | (1) Less than 100 patients (2) 1 patient Age distribution💬 | Pediatric diseases |
268 | Nakajo-Nishimura syndrome "Autoinflammation, lipodystrophy, and dermatosis syndrome", "CANDLE syndrome", "JMP syndrome", "Nakajo syndrome" | 1 1 trial 0 / 1 / 1 / 0 💬 | 1 1 drug [ 1 1 drug ] | 2 2 genes 33 pathways | (1) Less than 100 patients (2) 6 patients Age distribution💬 | Biobank Pediatric diseases |
269 | Pyogenic arthritis "Pyoderma gangrenosum", "Acne syndrome", "PAPA syndrome" | 20 20 trials 6 / 12 / 7 / 1 💬 | 26 26 drugs [ 10 10 drugs ] | 12 12 genes 90 pathways | (1) Less than 100 patients (2) 8 patients Age distribution💬 | Pediatric diseases |
270 | Chronic recurrent multifocal osteomyelitis | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) 77 patients Age distribution💬 | Pediatric diseases |
271 | Ankylosing spondylitis "Spondylarthritis ankylopoietica" | 531 531 trials 299 / 142 / 221 / 108 💬 | 343 343 drugs [ 66 66 drugs ] | 41 41 genes 141 pathways | (1) About 4,500 patients (2) 4,219 patients Age distribution💬 | |
272 | Fibrodysplasia ossificans progressiva "FOP" | 23 23 trials 31 / 19 / 10 / 6 💬 | 21 21 drugs [ 4 4 drugs ] | 10 10 genes 87 pathways | (1) Less than 100 patients (2) 23 patients Age distribution💬 | Biobank Pediatric diseases |
273 | Congenital scoliosis with rib anomaly "Congenital scoliosis" | 0 - | 0 - | 0 - | (1) Less than about 2,000 patients (Children under 11) (2) 24 patients Age distribution💬 | Pediatric diseases |
274 | Osteogenesis Imperfecta | 78 78 trials 49 / 23 / 27 / 15 💬 | 87 87 drugs [ 19 19 drugs ] | 14 14 genes 74 pathways | (1) About 6,000 patients (2) 113 patients Age distribution💬 | Biobank Animal model Pediatric diseases |
275 | Thanatophoric dysplasia | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) 5 patients Age distribution💬 | |
276 | Achondroplasia | 37 37 trials 31 / 27 / 13 / 6 💬 | 29 29 drugs [ 6 6 drugs ] | 4 4 genes 25 pathways | (1) 6,000 patients nationwide (estimated by frequency of occurrence) (2) 85 patients Age distribution💬 | Biobank Animal model Pediatric diseases |
277 | Lymphangiomatosis "Generalized lymphatic anomaly", "Gorham disease", "Gorham-Stout disease", "Diffuse lymphangiomatosis", "Mass osteolysis" | 7 7 trials 2 / 2 / 2 / 0 💬 | 2 2 drugs [ 2 2 drugs ] | 1 1 gene 50 pathways | (1) About 100 patients (estimated by the national survey of the research group) (2) 44 patients Age distribution💬 | Pediatric diseases |
278 | Huge lymphatic malformation with cervicofacial lesion "Huge lymphatic malformation", "Lymphatic malformation" | 19 19 trials 12 / 11 / 5 / 3 💬 | 23 23 drugs [ 7 7 drugs ] | 5 5 genes 62 pathways | (1) About 600 patients (2) 14 patients Age distribution💬 | Pediatric diseases |
279 | Huge venous malformation with cervical, oral and pharyngeal diffuse lesion oral and pharyngeal diffuse lesion", "Huge venous malformation", "Venous malformation" | 12 12 trials 2 / 5 / 1 / 2 💬 | 23 23 drugs [ 9 9 drugs ] | 3 3 genes 103 pathways | (1) About 200 patients (2) 48 patients Age distribution💬 | Pediatric diseases |
280 | Huge arteriovenous malformation with cervicofacial or limb lesion "Huge arteriovenous malformation", "Arteriovenous malformation" | 22 22 trials 14 / 6 / 2 / 4 💬 | 26 26 drugs [ 13 13 drugs ] | 11 11 genes 147 pathways | (1) About 700 patients (2) 105 patients Age distribution💬 | Pediatric diseases |
281 | Klippel-Trenaunay-Weber syndrome "Klippel-Trenauney-Weber syndrome", "Klippel-Trenaunay syndrome", "Klippel-Trenauney syndrome", "KTS", "Parkes Weber syndrome", "PWS" | 1 1 trial 0 / 0 / 0 / 0 💬 | 1 1 drug [ 1 1 drug ] | 1 1 gene 50 pathways | (1) About 3,000 patients (2) 236 patients Age distribution💬 | Pediatric diseases |
282 | Congenital dyserythropoietic anemia "CDA" | 1 1 trial 0 / 0 / 0 / 1 💬 | 1 1 drug [ 1 1 drug ] | 2 2 genes 4 pathways | (1) Less than 100 patients (2) 9 patients Age distribution💬 | Pediatric diseases |
283 | Acquired pure red cell aplasia "Pure red cell aplasia" | 17 17 trials 7 / 11 / 2 / 5 💬 | 36 36 drugs [ 19 19 drugs ] | 16 16 genes 91 pathways | (1) Incidence per year: 0.3 patients per one million population (2) 818 patients Age distribution💬 | Pediatric diseases |
284 | Diamond-Blackfan anemia | 37 37 trials 18 / 26 / 4 / 2 💬 | 110 110 drugs [ 34 34 drugs ] | 22 22 genes 121 pathways | (1) About 200 patients (2) 23 patients Age distribution💬 | Pediatric diseases |
285 | Fanconi anemia | 56 56 trials 27 / 39 / 3 / 1 💬 | 111 111 drugs [ 31 31 drugs ] | 30 30 genes 151 pathways | (1) About 200 patients (2) 12 patients Age distribution💬 | Biobank Pediatric diseases |
286 | Hereditary sideroblastic anemia "Congenital sideroblastic anemia", "Sideroblastic anemia" | 6 6 trials 5 / 1 / 1 / 1 💬 | 13 13 drugs [ 5 5 drugs ] | 0 - | (1) Less than 100 patients (2) 12 patients Age distribution💬 | Pediatric diseases |
287 | Epstein syndrome | 0 - | 0 - | 0 - | (1) About 200 patients (2) 12 patients Age distribution💬 | Pediatric diseases |
288 | Autoimmune acquired coagulation factor deficiency "Coagulation factor deficiency", "Factor XIII deficiency", "Factor VIII deficiency", "Acquired hemophilia A", "von Willebrand Disease", "Factor V deficiency" | 189 189 trials 68 / 31 / 84 / 30 💬 | 219 219 drugs [ 29 29 drugs ] | 18 18 genes 26 pathways | (1) About 700 patients (2) 423 patients Age distribution💬 | |
289 | Cronkhite-Canada syndrome | 0 - | 0 - | 0 - | (1) About 500 patients (2) 189 patients Age distribution💬 | |
290 | Chronic nonspecific multiple ulcers of the small intestine "Nonspecific multiple ulcers in the small intestine" | 1 1 trial 1 / 1 / 0 / 0 💬 | 1 1 drug [ 1 1 drug ] | 1 1 gene 1 pathway | (1) About 200 patients (2) 85 patients Age distribution💬 | Pediatric diseases |
291 | Hirschsprung disease, entire colon type entire colon type", "Hirschsprung disease, small intestine type", "Hirschsprung disease", "Hirschprung disease", "Hirschsprung disease associated entercolitis" | 13 13 trials 0 / 1 / 1 / 1 💬 | 32 32 drugs [ 15 15 drugs ] | 0 - | (1) About 10,000 patients (Among them, entire colon type and small intestine type: About 1,000 patients) (2) 12 patients Age distribution💬 | Pediatric diseases |
292 | Cloacal exstrophy "Vesicointestinal fissure" | 0 - | 0 - | 0 - | (1) About 300 patients (2) 14 patients Age distribution💬 | Pediatric diseases |
293 | Persistent cloaca | 0 - | 0 - | 0 - | (1) About 600 patients (2) 41 patients Age distribution💬 | Pediatric diseases |
294 | Congenital diaphragmatic hernia | 12 12 trials 6 / 2 / 5 / 2 💬 | 29 29 drugs [ 6 6 drugs ] | 5 5 genes 14 pathways | (1) About 5,000 patients (2) 8 patients Age distribution💬 | Pediatric diseases |
295 | Infant huge hepatic hemangioma "Infant giant liver hemangioma" | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) - Age distribution💬 | Pediatric diseases |
296 | Biliary atresia | 53 53 trials 6 / 12 / 10 / 3 💬 | 56 56 drugs [ 31 31 drugs ] | 43 43 genes 50 pathways | (1) About 3,500 patients (2) 373 patients Age distribution💬 | Pediatric diseases |
297 | Alagille syndrome | 26 26 trials 12 / 17 / 2 / 2 💬 | 16 16 drugs [ 8 8 drugs ] | 2 2 genes 2 pathways | (1) About 200~300 patients (2) 39 patients Age distribution💬 | Pediatric diseases |
298 | Hereditary pancreatitis "Chronic pancreatitis" | 93 93 trials 19 / 26 / 17 / 7 💬 | 168 168 drugs [ 51 51 drugs ] | 48 48 genes 134 pathways | (1) About 300~400 patients (2) 25 patients Age distribution💬 | Pediatric diseases |
299 | Cystic fibrosis | 1,592 1,592 trials 783 / 493 / 523 / 227 💬 | 1,539 1,539 drugs [ 255 255 drugs ] | 81 81 genes 162 pathways | (1) Less than 100 patients (2) 13 patients Age distribution💬 | Pediatric diseases |
300 | IgG4-related disease "Autoimmune pancreatitis", "IgG4-related sclerosing cholangitis", "IgG4-related lacrimal gland, orbital, and salivary gland lesions", "IgG4-related kidney disease" | 31 31 trials 4 / 7 / 10 / 4 💬 | 33 33 drugs [ 16 16 drugs ] | 11 11 genes 81 pathways | (1) About 8,000 patients (2) 3,016 patients Age distribution💬 | Pediatric diseases |
301 | Macular dystrophy "Best disease", "Stargardt disease", "Cone dystrophy", "Cone rod dystrophy", "X-linked juvenile retinoschisis", "Central areolar choroidal dystrophy" | 41 41 trials 25 / 25 / 7 / 2 💬 | 47 47 drugs [ 12 12 drugs ] | 12 12 genes 66 pathways | (1) 1,000 patients (2) 202 patients Age distribution💬 | Animal model |
302 | Leber hereditary optic neuropathy | 20 20 trials 27 / 10 / 15 / 6 💬 | 14 14 drugs [ 4 4 drugs ] | 5 5 genes 32 pathways | (1) Estimated number of new occurrences per year: 117 patients (2) 134 patients Age distribution💬 | |
303 | Usher syndrome | 6 6 trials 9 / 6 / 1 / 1 💬 | 11 11 drugs [ 0 - ] | 0 - | (1) About 8,160 patients (2) 19 patients Age distribution💬 | |
304 | Juvenile-onset bilateral sensorineural hearing loss | 0 - | 0 - | 0 - | (1) About 4,000 patients (2) 35 patients Age distribution💬 | |
305 | Delayed endolymphatic hydrops | 1 1 trial 0 / 0 / 0 / 0 💬 | 1 1 drug [ 1 1 drug ] | 0 - | (1) About 4,000~5,000 patients (2) 31 patients Age distribution💬 | |
306 | Eosinophilic sinusitis | 0 - | 0 - | 0 - | (1) About 20,000 patients (2) 13,404 patients Age distribution💬 | |
307 | Canavan disease | 3 3 trials 1 / 1 / 0 / 0 💬 | 5 5 drugs [ 1 1 drug ] | 0 - | (1) A few patients (2) 1 patient Age distribution💬 | Pediatric diseases |
308 | Progressive leukoencephalopathy "Megalencephalic leukoencephalopathy with subcortical cyst", "Leukoencephalopathy with vanishing white matter", "Leukoencephalopathy, progressive, with ovarian failure" | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) 17 patients Age distribution💬 | Pediatric diseases |
309 | Progressive myoclonus epilepsy "Unverricht-Lundborg disease", "Lafora disease", "Benign adult familial myoclonus epilepsy", "BAFME" | 11 11 trials 0 / 0 / 3 / 0 💬 | 15 15 drugs [ 2 2 drugs ] | 4 4 genes 9 pathways | (1) About 3,000 patients (2) 33 patients Age distribution💬 | Biobank Pediatric diseases |
310 | Congenital anomalies syndrome "Trisomy 1q", "9q34 deletion syndrome", "Cornelia de Lange syndrome", "CdLS", "Smith-Lemli-Opitz syndrome", "SLO syndrome" | 10 10 trials 2 / 7 / 0 / 0 💬 | 18 18 drugs [ 10 10 drugs ] | 3 3 genes 7 pathways | (1) About 4,000 patients (2) 28 patients Age distribution💬 | Pediatric diseases |
311 | Congenital tricuspid stenosis | 0 - | 0 - | 0 - | (1) About 500 patients (2) 2 patients Age distribution💬 | Pediatric diseases |
312 | Congenital mitral stenosis | 0 - | 0 - | 0 - | (1) About 100 patients (2) 8 patients Age distribution💬 | Pediatric diseases |
313 | Congenital pulmonary vein stenosis | 0 - | 0 - | 0 - | (1) About 80 patients (2) 1 patient Age distribution💬 | Pediatric diseases |
314 | Vascular sling | 0 - | 0 - | 0 - | (1) About 600 patients (2) 2 patients Age distribution💬 | Pediatric diseases |
315 | Nail-Patella syndrome "LMX1B-associated nephropathy" | 0 - | 0 - | 0 - | (1) About 500 patients (2) 7 patients Age distribution💬 | Pediatric diseases |
316 | Carnitine cycle disorder "Carnitine palmitoyltransferase I deficiency", "CPT1 deficiency", "Carnitine palmitoyltransferase II deficiency", "CPT2 deficiency", "Carnitine-acylcarnitine translocase deficiency", "CACT deficiency", "Carnitine transporter deficiency", "OCTN-2 deficiency" | 4 4 trials 0 / 1 / 1 / 0 💬 | 10 10 drugs [ 4 4 drugs ] | 2 2 genes 9 pathways | (1) About 960 patients (2) 13 patients Age distribution💬 | Pediatric diseases |
317 | Trifunctional protein deficiency | 3 3 trials 0 / 0 / 0 / 0 💬 | 8 8 drugs [ 4 4 drugs ] | 1 1 gene 1 pathway | (1) Less than 100 patients (2) 3 patients Age distribution💬 | Pediatric diseases |
318 | Citrin deficiency "NICCD", "Adult-onset type II citrullinemia", "CTLN2" | 2 2 trials 0 / 1 / 0 / 0 💬 | 2 2 drugs [ 2 2 drugs ] | 0 - | (1) About 1,500 patients (2) 51 patients Age distribution💬 | Biobank Animal model Pediatric diseases |
319 | Sepiapterin reductase deficiency | 0 - | 0 - | 0 - | (1) Less than 100 patients (About one patient) (2) 2 patients Age distribution💬 | |
320 | Inherited glycosylphosphatidylinositol deficiency "Congenital glycosylphosphatidylinositol deficiency" | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) - Age distribution💬 | Pediatric diseases |
321 | Non-ketotic hyperglycinemia | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) 1 patient Age distribution💬 | Pediatric diseases |
322 | Beta-ketothiolase deficiency | 0 - | 0 - | 0 - | (1) Less than 100 patients (2) - Age distribution💬 | Pediatric diseases |
323 | Aromatic L-amino acid decarboxylase deficiency | 0 - | 0 - | 0 - | (1) Less than 100 patients (About 10 cases) (2) 3 patients Age distribution💬 | Pediatric diseases |
324 | Methylglutaconic aciduria "3-methylglutaconyl-CoA hydratase deficiency", "3-MGA", "Barth syndrome", "Costeff syndrome", "Mitochondrial respiratory chain disorder", "Dilated cardiomyopathy with ataxia syndrome", "DCMA syndrome" | 3 3 trials 5 / 2 / 2 / 1 💬 | 4 4 drugs [ 3 3 drugs ] | 1 1 gene 8 pathways | (1) Less than 100 patients (2) - Age distribution💬 | Pediatric diseases |
325 | Hereditary autoinflammatory syndrome "NLRC4 abnormality", "Adenosine deaminase 2 deficiency", "ADA2 deficiency", "Aicardi-Goutieres syndrome", "A20 haploinsufficiency" | 6 6 trials 1 / 5 / 1 / 0 💬 | 10 10 drugs [ 6 6 drugs ] | 2 2 genes 33 pathways | (1) Less than 100 patients (Adult patients reported in all cases) (2) 9 patients Age distribution💬 | Pediatric diseases |
326 | Osteopetrosis | 20 20 trials 5 / 13 / 4 / 0 💬 | 52 52 drugs [ 14 14 drugs ] | 16 16 genes 78 pathways | (1) About 100 patients (2) 21 patients Age distribution💬 | Animal model Pediatric diseases |
327 | Idiopathic thrombosis | 0 - | 0 - | 0 - | (1) Based on the national survey of the research group, the total number of patients in Japan is estimated as about 2,000 patients. Occurrence per year in naonates and infants: Less than 100 patients, in adult: About 500 patients. (2) 177 patients Age distribution💬 | Pediatric diseases |
328 | Anterior segment dysgenesis | 0 - | 0 - | 0 - | (1) About 6,000 patients (2) 14 patients Age distribution💬 | |
329 | Aniridia | 3 3 trials 0 / 2 / 0 / 0 💬 | 2 2 drugs [ 2 2 drugs ] | 0 - | (1) About 1,200 patients (2) 115 patients Age distribution💬 | |
330 | Congenital tracheal stenosis / Congenital subglottic stenosis [Congenital tracheal stenosis (~Mar 2018)] "Congenital tracheal stenosis", "Congenital subglottic stenosis" | 1 1 trial 0 / 1 / 0 / 0 💬 | 3 3 drugs [ 2 2 drugs ] | 0 - | (1) About 1,000 patients (2) 29 patients Age distribution💬 | Pediatric diseases |
331 | Idiopathic multicentric castleman disease "Castleman disease" | 30 30 trials 16 / 20 / 2 / 3 💬 | 44 44 drugs [ 23 23 drugs ] | 30 30 genes 148 pathways | (1) About 1,500 patients (2) 1,354 patients Age distribution💬 | |
332 | Gelatinous drop-like corneal dystrophy | 0 - | 0 - | 0 - | (1) About 400 patients (2) 2 patients Age distribution💬 | |
333 | Hutchinson-Gilford syndrome "Hutchinson-Gilford progeria syndrome", "HGPS" | 7 7 trials 2 / 5 / 0 / 0 💬 | 8 8 drugs [ 3 3 drugs ] | 4 4 genes 6 pathways | (1) Less than 100 patients (2) - Age distribution💬 | Pediatric diseases |